Embed Size (px)
DESCRIPTION
jooo
Citation preview
Nomination for Country WHO region Title First Name
Board of Directors Algeria Africa Mr. MohamedBoard of Directors D.R. Congo Africa Dr. Jason
Board of Directors Kenya Africa Mr. David Makumi
Board of Directors Nigeria Africa Prof. Ifeoma
Board of Directors Sierra Leone Africa Mr. Joseph
Board of Directors Tanzania Africa Dr. Twalib A.
Board of Directors Brazil Americas Dr. Maira
Board of Directors Brazil Americas Dr. Luiz Antonio
Board of Directors Canada Americas Dr. Healther
Board of Directors Costa Rica Americas Dr. Maria del Rocío
Board of Directors Peru Americas Dr. Carlos S.
Board of Directors USA Americas Dr. Benjamin O.
Board of Directors USA Americas Mr. Gregory P.
Board of Directors USA Americas Dr. MarkBoard of Directors USA Americas Prof. Jonathan
Board of Directors USA Americas Prof. Elizabeth
Board of Directors USA Americas Dr. Michelle
Board of Directors USA Americas Dr. Nora Anita
Board of Directors USA Americas Dr. Felicia
Board of Directors USA Americas Prof. Chang Ming Charlie
Board of Directors USA Americas Dr. Leslie
Board of Directors USA Americas Dr. Sofia
Board of Directors USA Americas Prof. Subir
Board of Directors USA Americas Dr. Rola
Board of Directors USA Americas Dr. Vinod
Board of Directors USA Americas Dr. Dong Moon
Board of Directors USA Americas Prof. Peter
Board of Directors USA Americas Mrs. Amanda
Board of Directors USA Americas Mr. Douglas E.
Board of Directors USA Americas Dr. Yun
Board of Directors Iran Eatern MediterraDr. Kazem
Board of Directors Jordan Eatern MediterraDr. Jamal
Board of Directors Kuwait Eatern MediterraDr. Khaled
Board of Directors Saudi Arabia Eatern MediterraDr. Samia
Board of Directors UAE Eatern MediterraMs. Ameera
Board of Directors Austria Europe Prof. Michael
Board of Directors France Europe Prof. Jean
Board of Directors France Europe Prof. Gilbert
Board of Directors France Europe Prof. Martine
Board of Directors Germany Europe Prof. Rudiger
Board of Directors Germany Europe Prof. Ulrich R.
Board of Directors Germany Europe Prof. Ludwig G.
Board of Directors Israel Europe Prof. Raphael
Board of Directors Israel Europe Prof. Dan
Board of Directors Italy Europe Dr. PietroBoard of Directors Norway Europe Mrs. Anne-Lise
Board of Directors Poland Europe Prof. Barbara
Board of Directors Romania Europe Dr. Radu Lucian
Board of Directors Serbia Europe Mrs. Marijana
Board of Directors Spain Europe Dr. Maria Isabel
Board of Directors Spain Europe Prof. Antonio
Board of Directors Turkey Europe Prof. Tezer
Board of Directors UK Europe Ms. Marilyn
Board of Directors Bangladesh South East Asia Prof. Mollah Obayedullah
Board of Directors India South East Asia Dr. Anil Keith
Board of Directors India South East Asia Mrs. Jyotsna
Board of Directors India South East Asia Prof. Kim
Board of Directors Indonesia South East Asia Dr. Adityawati
Board of Directors Nepal South East Asia Dr. Prakash Raj
Board of Directors Nepal South East Asia Dr. Madan
Board of Directors Sri Lanka South East Asia Dr. Samadhi
Board of Directors Thailand South East Asia Prof. Khunying Kobchitt
Board of Directors Australia Western Pacific Prof. Sanchia
Board of Directors Australia Western Pacific Dr. Jeffrey
Board of Directors Australia Western Pacific Prof. Ian
Board of Directors China Western Pacific Dr. Ning
Board of Directors China Western Pacific Prof. Guozheng
Board of Directors/OBS China Western Pacific Prof. Xishan
Board of Directors Japan Western Pacific Dr. Kazuo
Board of Directors Malaysia Western Pacific Dr. Mohamed Ibrahim A.
Board of Directors Philippines Western Pacific Dr. Cecilia
Nomination for Country WHO region Title First Name
President-Elect Guatemala Americas Dr. Miguel
President-Elect USA Americas Dr. Dileep G.
President-Elect Switzerland Europe Dr. Franco
President-Elect Turkey Europe Prof. Tezer
President - Elect Turkey Europe Prof. Aptullah Murat
President-Elect Bangladesh South East Asia Prof. AFM Ruhal
President-Elect China Western Pacific Dr. Chen
Not complete
BOLD = COMPLETEBOLD = COMPLETE
Cancellations
Board of Directors Belgium Europe Prof. Ian
Board of Directors Australia Western Pacific Prof. Christopher
Last Name Nominee - Position
DebabsiaKikuhe Nzandzu President
Kinyanjui Vice President
Okoye Chair
Bundor Tarawally Director
Ngoma Chief Executive Officer
Caleffi President
Santini Director General
Bryant Vice President, Cancer ControlSaenz Madrigal Coordinator of Health Policies
Vallejos Jefe Institucional
Anderson Chair and Director
Brontager Chief Operating Officer
Clanton Chief Medical OfficerFinlay Professor of Pediatrics
Terrel Fontham
Holmes Associate Professor
Janjan Senior Fellow
Knaul Director
Ma Director and Vice Chair
Mancuso President & CEO
Merajver
Nag Director of Brachytherapy
Shaheen
Shidham
Shin
Stambrook Professor
Tucker
Ulman President & CEO
Yen
Zendehdel Deputy of Research
Khader
Al Saleh General Secretary
Al-Amoudi CEO and Founder
Binkaram
Marberger Professor & Chairman
Bourhis Dept of Radiotherapy
Lenoir President
Raphael
Hehlemann Professor
Kleeberg Board member
Strauss
Catane Professor & Chairman, Division of
Fliss Professor & Chairman
Head of Department, Management jobs & skills
Dean and Professor of Epidemiology
Professor of Internal Medicine,; Scientific Director, Breast Oncology Programme; Director Breast & Ovarian Cancer Risk Evaluation ProgramChief of Radiology and Director of Women’s ImagingVice-chair- AP, Professor, and Director of Cytopathology Professor and Vice Chair, Department of Hematolgy/Medical Oncology
Director - LIVESTRONG Business Development
Physician and President of Taipei Medical University
Director International Extramural Affairs Office Director,
President and the founding member of the Board of Trustees
Vice Presidence and Medical Director
Head, Medical PET Group, Biological Imaging
Presti DirectorRyel Chief Executive Officer
Jarzab Vice Chairman Scientific Board
Buzulica MD, PhD
Slankamenac Manager for medical waiste
Izarzugaza
Llombart bosch President
Kutluk President
Gentry President & CEO
Baki President
D'Cruz Director
Govil Vice Chairman
Vaiphei Professor
Ganggaiswari Medical Secretary
Neupane Senior consultant and Chair
Piya Chairman & Director
Rajapaksa President
Limpaphayom
Aranda Director
Dunn Chief Executive Officer
Olver Chief Executive Officer
Geng Staff Scientist, Pathologist
Guo Professor and Head of department
Hao Vice President
Tajima Director
Wahid President
Llave Programme Director
Last Name Nominee - Position
Garces
Bal
Cavalli Head of Oncology
Kutluk President
Tuncer Rector
Haque Minister of Health
Zhu Professor, Academician
Jefe Scio. de Registros e Información Sanitaria
Honorary Doctorate in Medicine & Prof. Emeritus
Coordinator, Tobacco Control Division Clinical ProfessorDistrict Health Officer
Magrath Director
Parish Professor and Leader
Organization Phone number
ENSP, Subsidiary of Int. Petroleum Algerian SAONATRACH 213554684143Médecins Unis en Mission (MUM) 243 813 622 881
Aga Khan University Hospital 254 727 585 336
Breast Without Spot 234 803 331 4449
Crusaders Club Ministry 232 76 710367
255 222 1275 97
FEMAMA 55 5 130 940 017
INCA 55 21 32071006
1 416 619 5748Central America's National University 506 8844-4411
511 2016500 ex 1101University of Washington 1 206 543-6352
American Cancer Society 1 404 329 7660American Cancer Society 1 512-919-1803Keck School of Medicine, University of Southern California 001-323-361-8165
Louisiana State University School of Public Health 1 504 568 5700
Harvard University +1 617 820 8035
National Center for Policy Analysis
1 617 4327 938
Fox Chase Cancer Center 1-215-728-2996
Jhpiego 1 410 537 1879University of Michigan Comprehensive Cancer Center 1 734 936 68 84
Kaiser Permanente Northern California 1 408 851 8085
Harrington Memorial Hospital & Harvard Medical School
1 313 745 0831Emory University School of Medicine Winship Cancer Institute 404-778-5990
University of Cincinnati 1 513 558 6151
Nike, Inc and Livestrong 1 503-970-0450
1 512 236 8820 Ext 1150
City of Hope 1 626 256 4673 - Ext. 65707
Cancer Research Center, Cancer Institute of Iran +98 21 66561542
King Hussein Cancer Centre 96 2 796 57 55 53965 2253 0184
96 6505 6 2 6441Friends Of Cancer Patients 971 6506 5542University of Vienna 43 1 404 002 616 or 43 66 41 62 44 13
Institut Gustave Roussy 33 1 4211 4998
Ligue Nationale Française Contre le Cancer 33 1 53 55 24 23AMCC 33 6 16 75 26 20University of Heidelberg Medical School
German Cancer Society 0049 40 380 212 60
Deutsches Krebsforschungszentrum 0049 6221 42 2500 or 2477
The Chaim Sheba Medical Center, Tel Hashomer, Israel 972-3-5302064
Tel Aviv Sourasky Medical Center 972-3-697-3573
Ocean Road Cancer Institute
Canadian Partnership Against Cancer
Instituto Nacional de Enfermedades Neoplásicas (INEN)
1 936 825 9257 or 1 936 668 1884
Harvard Global Equity Initiative
Wayne State University School of MedicineKarmanos Cancer Center, & Detroit Medical Center
Lance Armstrong Foundation
Kuwait Society for Smoking and Cancer PreventionSheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer
"Edo ed Elvo Tempia" Foundation 39 333 439 9428Norwegian Cancer Society 47 22 86 66 10
Maria Sklodowska-Curie National Cancer Centre 48 32 278 9301
District Hospital 40740149551
Oncplogy Institute of Vojvodina 381641287964
Dpto. de Sanidad del Gobierno Vasco 34 94 416 9205
Fundacion Instituto Valenciano de Oncologia 34630892287
World Cancer Research Fund International 44207 343 4201Bangladesh Cancer Society 88 1710 941 199Tata Memorial Centre 91 22 2414 6685
Indian Cancer Society 91 11 26494907Post Graduate Institute of Medical Education & Research 91 9815912943
Indonesian Cancer Foundation 62 213 152 603977-9851025988
National Cancer Hospital 00977-1-5551376
Cancer Care Association 0094-11-2892979
Faculty of Medicine Chulalongkorn University 6622564175; 6626525253
Cancer Services and Information at the Cancer Institute of NSW 61438373488
Cancer Council Queensland 61 7.3634.5201Cancer Council Australia +61 2 8063 4100State Key Laboratories of Oran Diseases 86 1388 0060 542
The Fourth Military University 86-29-84774874
Chinese Medical Association 86 22 233593378152-764-2970
Malaysian Oncological Society
Organization Phone number
Faculty of Medical Sciences, University of San Carlos 502 2332 1577
1 808 241 3616
41 91 811 8666
90-312-4282818
Ministry of Health & Family Welfare
Chinese Academy of Sciences 86-21-64370045*610604
Turkish Association for Cancer Research & Control90 31 2442 0724/90 532
272 8123
Bhaktapyr Cancer Hospital
Aichi Cancer Center
60 3 76207979
The Cancer Institute Foundation, Inc.63 2 526134063 2 7719336
State of Hawaii Department of HealthUniversity of Hawaii At Manoa
ESO European School of OncologyOspedale San Giovanni
Turkish Association for Cancer Research & Control90 31 2442 0724/90 532
272 8123Hacettepe UniversityMinistry of Health
International Network for Cancer Treatment and Research 32 2 373 9324The John Curtin School of Medical Research +61 2 6125 2604
Address
Cité Frers Rahabi Bt 71 n°7 Guelma05, MULU Steet, KYESHERO
P.O BOX 5195, NAIROBI
College of Medicine, Enugu
80A Kissy Bye Pass Road
P.O. Box 3592, Dar Es Salaam
Ramiro Barcelos, 850
23 Pra, 4, Rio de Janeiro 20230-130
Suite 300, 1 University Avenue, Toronto
Av. Angamos Este 2520, Surquillo, Lima 34
250 Williams Street (NW), 30303-1002 Atlanta GA
High Plains Division, 2433-A Ridgepoint DriveChildren's Hospital Los Angeles, 4650 Sunset Blvd., Mailstop #54, Los
2020 Gravier Street, 3rd floor, New Orleans, Louisiana 70112
181 Longwood Ave, Boston MA 02115
12770 Coit Rd., Suite 800, Dallas, TX 75251-1339
651 Huntington Avenue, FXB Building, Suite 632, 02116 Boston MA
333 Cottman Av
1615 Thames Street STE 200, Baltimore, MD 21231
7217 East Medical Center Drive, Ann Arbor, Michigan 48109
3450 Homestead Road, Santa Clara, CA
160 Boylston st, Apt# 2165, Chestnut Hill, MA 02467
1365 Clifton Rd NE C3094
Department of Molecular Genetics, Biochemistry and Microbiology
3570 SW River Parkway, Suite 1511, Portland, OR 97239
2201 East 6th Street, 78702 Austin TX
End Keshavarz Bulvard, Imam Khomeini Hospital, Cancer Institue of Ir
P.O.BOX 1269, 11964 Amman
St. 14, Al Qadisya, 26733 Kuwait KU
P.O. Box 611 Sharjah
Währinger Gürtel 18-20, 1090 Vienna
39 rue Camille Desmoulins, 94805 Villejuif
14 rue Corvisart, 75013 Paris
Moerkenstr. 47
Im Neuenheimer Feld 280, 69120 Heidelberg
The Chaim Sheba Medical Center, Tel Hashomer, Israel
Otolaryngology Head & Neck Surgery and Maxillofacial Surgery, 6 Weiz
Department of Surgery, 1959 NE Pacific Street, Room BB-437A, Box 356410, Seattle, Washington 98195
Old Hutzel Hospital, Dept of Cytology, 4707 St. Antoine Blvd, Detroit, MI 48201
Molecular Pharmacology Department, City of Hope, 1500 East Duarte Road, Duarte CA 91010
Hématologie, Hôpitaux Universitaires Paris Sud, Hôpital Bicêtre 78 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre
Via Giolitti, 48, 10123, TorinoTullins gate 2, 0166 Oslo
MSC Memorial Cancer Center and Institute of Oncology, Gliwice Branc
107 Calomfirescu street
Institutski put 4
Ribera 14, 4º B, Es. Dcha, 48005 Bilbao
Calle Beltran Baguena 9, Avda Blasco Ibañez 8, 46010 Valencia V
Atac Sokak No:21/1 06410 Yenisehir-Ankara
22 Bedford Square - WC1B 3HH London
120/3-C, Darus Salam, Mirpur 1, Dhaka 1216
E. Borges Marg, Parel, Mumbai 400 012
86/1, Shahpur Jat, New Delhi
Jl.Dr.GSSY.Ratulangie no.35
P O Box 8975, EPC 2950, Kathmandu
3/18-20 Newton Street, Alexandria, 2015 Sydney NSW
GPO Box 4708, Sydney, NSW 2010
West China College of Stomatology, Sichuan University
286-B-801, Changle Xilu 17, Xi’an Shaanxi 710032
CACA - HuanHuXi Rd. Tiyuanbei, Hexi District, Tianjin 300060
1-1, Kanokoden, Chikusa-ku, 464-8681 Nagoya 23
1 Lorong Bukit Pantai 7, Bukit Pantai, 59100 Kuala Lumpur
Address
6a avenida 3-69 zona 10, Noveno nivel
Kauai District Health Office, 3040 Humi Street, Lihue, Kauai HI96766
Ospedale San Giovanni, 6500 Bellinzona
Atac Sokak No:21/1 06410 Yenisehir-Ankara
ABC Child Health Center, The New Hope in Health Foundation, Kırlan
Research Block A PGIMER Sector 12Department of Histopathology, Fifth Floor 160012 Chandigarh PB
Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok 10330
William Rudder House, 553 Gregory Terrace, Fortitude Valley Qld 4006
Cancer Institute Philippine General Hospital, Padre Faura St, Manila
Rue Engeland 642 - 1180 BrusselsBuilding 131, Garran Road, ACTON ACT
Email address Summary of International Experience
[email protected] or [email protected]
[email protected]@aol.com Dr. Finlay is internationally recognized as one
1.Texas A&M University International Programs A
[email protected] Dr. Prof. Ma has been an active member of many
[email protected] Dr. Nag has presented symposia, lectures and w
In addition to tobacco control, I have also wor
[email protected] or [email protected]
[email protected] Already present at the secretariat in Geneva, p
I volunteer to prepare a film with a group of researchers on cancer in 2012
[email protected] or [email protected]
1. Co-Chair, Palliative Care Study Group, Multinational Association of Supportive Care in Cancer.(www.mascc.org). A multinational Association whose mission is to to provider clinical and research leadership in all aspects of supportive care. 2. Completed several projects aimed at improving cancer care delivery and or education through International collaborations. This include • Project Leader, World Council of Enterostomal Therapists (www.wcetn.org) introduction of Stomal Nursing Education in Kenya Project. This has seen international faculty make two visits in the past 2 years to train Kenyan Nurses.
• Project Leader. International Union against Cancer (UICC) Introduction to Chemotherapy course for nurses through international faculty visits 2009- 2. Numerous international Speaking engagements in conferences and workshops in the area of cancer control and cancer care in resource poor settings. This include but not limited to:
Nursing Response to the Cancer Problem in developing World. Presented in the Oncology Nurses Society 36th Congress, Boston USA April, 2011
When the Hospital goes to the Shopping Mall! Building Partnerships with retail outlets to increase access to breast health programs. Presented in East Central and Southern Africa College of Nursing conference Lusaka, Zambia August 2010
Improving care of the Dying: Workshop(part II) presentation during the Multinational Association of Supportive Care in Cancer Symposium Vancouver, Canada 2010
Improving Care of the Dying (Part I) Workshop presentation during the Multinational Association of Supportive Care in Cancer Symposium. Rome, Italy 2009
A nurse led initiative: Establishment of the first hospital based cancer support group in a private healthcare institution in Kenya. Presented in the African Palliative Care Association (APCA www.apca.org ) conference, Nairobi 2007
Palliative care in resource Challenged environments. Presented at the 14th International Cancer Nurses Congress in Toronto, Canada. Oct, 2006.
Pain Management in the Context of the WHO Guidelines, World Cancer Congress, Washington DC. July 2006.
A synopsis of cancer pain management in Kenya: Oral presentation at the Oncology Nursing Society Congress, 2005, Orlando, Florida
Palliative care in Acute care setting: Gaps and challenges Presented in the 16th International conference of the Multinational Association of supportive care in cancer symposium – Miami, Florida. USA. June 2004.
As chairperson of Breast without spot a non-governmental organisation she has spearheaded the following: v Collaborating with a major Research Centre in Houston Texas to produce a proposal for a study to look at pre-menopausal women suffering breast cancer to understand incidence, impact, predisposition, genetic, and dietary. Same study will also look at oestrogen resistant breast cancer as it appears to be common in Nigerian women too. Proposal is to be completed and submitted in June. Through Breast without spot Prof Ifeoma Okoye has done the following o Collaborated with a government agency (National Youth Service Corps) to use post university students doing national service on the NYSC programme (a one year mandatory service enforced by govt) to Set up a team of foot ‘soldiers’ whose goal is to work on community advocacy at a personal level and impact behaviour change by targeting both men and women as well as school going children. o Developed a training manual for training of these Foot Soldiers (an army of advocates). The manual dwells on passing information on what Cancer is lifestyle changes for prevention and reducing risk, and details on Breast, Cervical and Prostate cancer and Case studies in order to teach the impact of untreated late disease on morbidity and mortality factors. So far we have trained over 5,500 of these youth corpers as cancer prevention advocates. Other advocacy tools produced by BWS include BSE posters and public health information leaflets on BSE and Cervical Cancer which are also used during community awareness sessions o These Foot soldiers are subsequently posted to the different communities (Called Local government areas), to sustain awareness on cancer prevention and screening, to teach BSE to as many women and men (for 70% of breast lumps are spouse detected), and to plant cancer prevention clubs in the secondary schools) o Building Medical Teams in States and Communities -Partnerships with healthcare providers so as to § Establish a referral navigation system to ensure timely referrals § Get them to also perform routine breast examination to their patients and also teach their patients to perform them (PCPs Gynaecologists & nurses) § Sustain regular cervical and prostate cancer screening o Developing Systematic Cancer control centres in collaboration with either LG or state health policy makers o Partnered BWS activities with other established NGOs in areas where these are well set up (e.g. Maria Sams in Lagos – by a survivor who have established medical teams for screening as well as helping to raise funding for treatment of the disease, COPE in Lagos to impact more effectively through media, Mana Foundation by the First lady of Adamawa, WLCF (Women Life Care Foundation) in Enugu who conduct the capacity building for VIA Cervical screening and the screening for BWSs, Prompt Healthcare, Ego Bekee Cancer Foundation, ‘Stand upto Cancer Niger’ and Medicaid foundation all in Abuja , and ‘Cancer awareness’ in Owerri Imo state and several others, as well as professional groups like ‘The Nigerian Medical Association, Medical Women Association, Association of Medical Students and West African College of Nurses – Nigerian Chapter ) to synergize efforts in tackling the disease
It is a Faith Based Organization that reach people through holistic approach. I have implemented several local as well as international projects successfully. In year 2010 I successfully implemented the Global Cancer Awareness Campaign, and in the year 2011 the Cancer Life Celebration for Kids Year 2011. I have also implemented other international projects. I have a good track record and besides, I have a wealth of experience. My resume is attached. Crusaders Club Ministry Sierra Leone is a member of UICC
Dr. Maira Caleffi was trained at Guy’s Hospital in London as a clinical research fellow from the Imperial Cancer Research. Between 1983 and 1988, she developed her doctoral thesis at the University of London, and undertook postdoctoral studies in molecular biology in the field of genetics and breast cancer at Vanderbilt University in Nashville, Tennessee. Dr. Caleffi is also a member of the American Cancer Society; American Society of Clinical Oncology (ASCO); Breast Health Global Initiative (BHGI); Global Leadership Forum for Cancer Control (GO PUBLIC); International Society for Pharma-economics and Outcomes Research (ISPOR); Lance Armstrong Association – LIVESTRONG; National Cancer Institute(NCI); Susan G Komen for The Cure - Global Initiative for breast Health Awareness; Breast Cancer Dialogue Series (BCDS) – NOVARTIS; The Harvard School of Public Health - Global Task Force on Expanded Access to Cancer Care and Control (GTF.CCC). She also participates of several international events such as the World Cancer Leaders Summit, since 2010, and the San Antonio Breast Cancer Symposium.
Dr. Bryant has served on the Governing Council of the International Agency for Research on Cancer, and was elected to the executive of the International Agency of Cancer Registries. She was a member of a WHO panel that helped outline the development of their cancer control handbooks. She has served on organizing committees of several international cancer conferences, including the UICC Cancer Congress in 2010 (Chair of Prevention Stream) and the upcoming 2012 Congress (Co-chair Scientific Committee). (see attached CV)
Dr. Saenz is an international expert in public health, disaster management, and health sector reform in Latin America. From 2002 until 2006, she was Minister of Health of Costa Rica, and consolidated the health system reforms initiated in the 1990s, with a focus on increasing the stewardship role of the Ministry of Health in research and development of health technologies, and ensuring equitable health financing. In 2005, she led the drafting of a new General Law of Health, which includes new chapters on sexual and reproductive health, bioethics, financing for health research, the use of genomes, and other important contributions to health promotion in Costa Rica. From 2004 to 2006 she coordinated the Social Council of Government in Costa Rica. Dr. Saenz has a broad spectrum of experience and expertise to bring to UICC ranging from her research and academic work to her time as Minister of Health of Costa Rica. She has worked extensively in the areas of health promotion, organization and financing; but is also an expert in the methodological preparation and implementation of projects, and planning and coordination among national and international actors, and government and non-governmental institutions alike. She was a member of the Board of Directors of the Pan American Health Organization, in which she participated in a Working Group on the challenges for PAHO in the 21st century. Currently, she is a member of the PAHO initiative on safe hospitals in the Americas. She is currently the Coordinator of Health Policies at National University's Health and Work Program for Central America. She is a professor at the University of Costa Rica's School of Public Health and Senior Adviser of the Health Observatory for Latin America and the Caribbean. Dr. Saenz is currently a member of several organization, including: College of Physicians and Surgeons of Costa Rica, Public Health Association of Costa Rica, and the Pan American Health Organization's initiative on safe hospitals. She is president of a foundation that promotes access to scientific information on disasters in Latin America and the Caribbean.
Dr. Vallejos is an active participating in collaborative clinical research with internatiotal academic groups. He support the research in the Institute Nacional de Enfermedades Neoplásicas. Since he is Director of this Institution, the number of publications in peer review journals has increased consideraby. In the same way, has increased the number of collaborative works to perform translational research. Dr. Vallejos achieved a sistership between MD ANderson and INEN, Also incorporate INEN to the Esartern cooperative Oncology Group (ECOG). Currently, Dr. Vallejos is the president of the SLACOM (Latinamerican and the Caribean Society of Medical Oncology).
As the chief operating officer for the American Cancer Society, Gregory P. Bontrager oversees the overall day-to-day operations of the world’s largest voluntary health organization. In this role, he provides leadership and direction to the Office of the Chief Mission Delivery Officer, Office of the Chief Financial Officer, Office of the Chief Counsel, the Office of Strategy, and to the field operations, Corporate IT, Corporate Communications, Talent Strategy, and Corporate Affairs and Strategic Governance functions. Additionally, he has a matrix supervisory relationship with the Society’s nonprofit, non-partisan 501(c)(4) advocacy affiliate, the American Cancer Society Cancer Action NetworkSM (ACS CAN). Mr. Bontrager reports directly to the Society’s Chief Executive Officer, John R. Seffrin, PhD. Mr. Bontrager’s leadership extends across the nationwide organization, and he serves as a member the CEO Cabinet, the senior-most staff leadership team within the enterprise. Mr. Bontrager also leads the Society’s National Home Office (NHO) Senior Leadership Team, the group of senior-most functional staff leaders within the headquarters operation, which provides strategic guidance for organization-wide business operations, including the planning, development, operation, and evaluation of Society mission delivery programs, income development initiatives, and support strategies. Mr. Bontrager also guides the work of the Nationwide Executive Team, comprised of the Society’s senior-most community staff – the CEOs of the organization’s affiliated Divisions. Prior to his current assignment, Mr. Bontrager served as deputy chief operating officer and chief mission officer at the NHO. Prior to these positions, he was chief executive of the Society’s Great Lakes Division, which encompasses the states of Michigan and Indiana. Under his leadership, the Division became one of the most successful of the Society’s 12 regional affiliates. This experience has provided his nationwide staff leadership with an innovative, community-based perspective.Mr. Bontrager first joined the American Cancer Society in 1988 as director of development for the former Michigan Division. He later served as the Division’s vice president of development, senior vice president for operations, chief operating officer, and chief executive officer. He is a member of the Board of Directors for the National Human Services Assembly, an association of the nation’s leading national non-profits in the fields of health, human and community development, and human services. He is also a past member of the Board of Directors of the Karmanos Cancer Institute, the Spring Arbor University Board of Trustees, and the Plante & Moran, LLP/Michigan State University Broad Graduate School of Management Masters Forum. Mr. Bontrager holds a bachelor’s degree in psychology and business administration from Spring Arbor University, a master’s degree in administration from Western Michigan University, and is a graduate of the Emory University Business School Executive Development Institute. Mr. Bontrager is a nationally licensed New York Stock Exchange broker with special emphasis on investment counseling. He is a past recipient of the Spring Arbor University Young Leader Award, and was selected as a Rotary International Young Business Leaders Exchange team member to Japan. Mr. Bontrager resides in Atlanta and is married to Karen Bontrager, who is an elementary school teacher.
Dr. Fontham is the Dean and Professor of Epidemiology at Louisiana State University (LSUHSC) School of Public Health and Professor of Pathology in the LSU School of Medicine. She has been on the faculty in the LSUHSC since 1980. She is also Associate Director of the Stanley S. Scott Cancer Center and is Senior Consultant Epidemiologist to the Louisiana Office of Public Health. Dr. Fontham’s major area of research is cancer epidemiology. She is internationally recognized for her research on the lung cancer risk from secondhand smoke exposure. She led the largest U.S. study of lung cancer in nonsmoking women that provided critical information leading to the classification of secondhand smoke as a human carcinogen. Dr. Fontham has also published extensively on stomach cancer and its risk factors, with studies in the high risk population in the Andes Mountains of Colombia. She is currently on a team of investigators studying human health effects of the BP Oil Spill in the Gulf in April 2010. She has served as a member of the NCI Board of Scientific Counselors. She was Treasurer and on the Board of Directors of the American College of Epidemiology of which she is a Fellow. She was a member of the inaugural Editorial Board of Cancer Epidemiology Biomarkers and Prevention; Chairman of the Scientific Editorial Board of the North American Association of Central Cancer Registries; and a contributing author for both the Surgeon General’s Report and International Agency for Cancer Research Carcinogenesis Monograph series. She is recipient of the Alton Ochsner Award Relating Tobacco and Health, the C.L. Brown Award for Leadership Excellence in Tobacco Prevention; the Leadership and Distinguished Service Award of the American College of Epidemiology; and the Pfizer Award for Excellence in Research, Education and Patient Care. Dr. Fontham is a long time active volunteer in the American Cancer Society at the local, division and national levels. She is past President of the American Cancer Society and served on the Board of Directors from 2001-2010. She has been a member of the ACS MidSouth Division Board and is past Chair and a member of the Executive Leadership Council of ACS Greater New Orleans. She has chaired or co-chaired numerous national committees of the Society. Locally she is a member of the Board of Directors of Catholic Charities-Archdiocese of New Orleans and has been a member of the Board of PACE (Provision of All Inclusive Care of the Elderly), the Board of Governors’ of Isidore Newman School, Friends of a Studio in the Woods, Louisiana Public Health Institute and other organizations.
Dr. Mancuso, a nurse by training, is a recognized international business leader with a track record of success in bringing accountability and navigating changes in the international nonprofit world. Dr. Mancuso has over 25 years of experience in developing public/private partnerships with organizations such as ExxonMobil, Laerdal Medical, GE Foundation, USAID, Chevron, Merck, GlaxoSmithKline and the Bill & Melinda Gates Foundation. Dr. Mancuso was appointed as Jhpiego’s President and CEO following a 13 year career with Project HOPE, where she served as COO and then as Acting CEO. Dr. Mancuso serves on many boards including the US-ASEAN Business Council, Inc., where she is acting Chair of the Health and Life Science Working Group, the Life Science Innovation Forum (LSIF) of the Asia Pacific Economic Cooperation Organization (APEC) and the World Trade Center Institute. Dr. Mancuso has also been the recipient of many prestigious business and professional awards including most recently the Ernst & Young Entrepreneur of the Year Award, the Smart CEO BRAVA Business Women Achievement Award, the Maryland International Business Leadership Award from the World Trade Center Institute, the Baltimore Daily Record Innovator of the Year Award and the Maryland Top 100 Women Award.
Dr Merajver has the leadership skills to steer large scientific organ based cancer programs (over 8 years and 2 comprehensive core grant submissions as scientific director of the breast program), a clinical enterprise in risk communication and management (one of the oldest or the oldest risk evaluation clinic), and a University wide Center for Global Health, a unit with multiple startegic objective sinvolving students and faculty from all units of the UM. She has experienc eith national and internationl symposia and with memoranda of understanding with ministries, hospitals, clinics, non governmental organizations and Universities.
[email protected] or [email protected]
Dr. Rola Shaheen is Chief of Radiology and the Director of Women’s Imaging at Harrington Memorial Hospital in Southbridge MA, a staff radiologist at Beth Israel Deaconess Medical Center (BIDMC) and an instructor in radiology at Harvard Medical School. In January 2011, Dr. Shaheen was appointed as the Regional Director for the Middle East by the Susan G. Komen Foundation for the Cure. She graduated from the Faculty of Medicine of Jordan University-Amman in 1996 and completed an internship and radiology residency at University of Toronto in 2007. She completed her women’s imaging fellowship at BIDMC. The majority of her practice is in women’s imaging with a focus on breast imaging, followed by obstetrics and gynecology ultrasounds. She has a particular interest in fetal MRI. Dr. Shaheen’s research interests include breast MRI and international public health projects focusing on promoting screening mammography in the Gaza Strip and the Middle East. Dr. Shaheen’s combined expertise and experience in clinical practice, scientific research and policy-oriented advocacy would be valuable to the UICC board, particularly given both her cross-cultural training as well as regional understanding of the Middle East. To further elaborate on her on-going experience, Dr. Shaheen is spearheading a study on comparative baseline needs assessment for breast cancer awareness and management in the Middle East, which is sponsored by the Susan G. Komen Foundation for the Cure. Dr. Shaheen serves on multiple national and international advisory committees including the Technical Advisory Committee for the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, the Jordan breast cancer program and Women's Cancer Foundation. Dr. Shaheen is an elected member of ARDMS for the global task force (EDTF) for breast examination. Additionally, Dr. Shaheen is also an active executive board member for the Middle East and North Africa partnership. She has given talks in gynecological ultrasound at national conferences such as the Radiological Society of North America (RSNA) and Society of Radiologists in Ultrasound (SRU). She is a Cum Laude award winner for an educational exhibit at RSNA. Dr. Shaheen is devoted to teaching medical students and radiology residents at Harvard Medical School. She has been an invited faculty speaker to national and international universities and is a longtime advocate for screening mammography and a believer in multidisciplinary clinical approach for management of breast cancer under one roof.
Dr. Shidham is an internationally known acclaimed cytopathologist and surgical pathologist with initiatives to extend its benefits globally through his initiative to publish all cytopathology research in open access for rapid free international dissemination under his leadership as President of Cytopathology Foundation by introducing an open access cytopathology journal- CytoJournal (www.cytojournal.com) in 2004. As one of the five premier cytopathology scientific journals, CytoJournal has a very elaborate editorial board http://www.cytojournal.com/editorialboard.asp organized under his leadership which includes many international scholars in the field. As obvious in his CV copy-pasted below,he has published and written widely on international scene including books and book chapters with many lectures, workshops, and symposia all over the world. He has active interest in teaching and training scholars interested in cytopathology and cytopathology with initiatives to support international colleagues. He has participated in different capacities in US national and international organizations and societies with commitment to integrate scientific gains globally by supporting and sponsoring different qualifying scholars including UICC research fellows.
1. Senior International Fogarty Fellow.2. Member of the Alexander Hollaender Committee which organizes and puts on workshops and syposia in scientifically developing countries for the benfit of its scientists. Participated in workshops in Colombia and Kazakhstan.3. Past President of the Environmental Mutagen Society (EMS) which, although a US society, has global membership.4. Visited China in 2008 on behalf of the Elsevier Publishing Company to speak at multiple venues and universities to young Chinese investigators about what is needed to publish in an English language journal.5. Member of COPE (Committee on Publication Ethics), an international organization that is establishing bsic guidelines for publication ethics.6. Member of the international advisory board for SCOPUS, a scientific search engine developed by Elsevier.7. Chair of the Content Selection Advisory Board: subcommittee for Molecular and biomedical sciences (Elsevier).8. Editor-in Chief of Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, an international journal.9. Scientific Director and Chair of the Scientific Advisory Board for the Israel Cancer Research Fund (ICRF).10. Scientific Advisory Board for the Ruder Boskovic Institute, Zagreb, Croatia.11. Invited speaker at multiple international symposia.
Amanda has an extensive international business background. She was the Director of International Labor and European Union Affairs with the U.S. Council for International Business from 1992-1996. She also worked for the International Labor Organization in Geneva, Switzerland from 1996-1999. Finally, she served as a Project Manager for Nike in Vietnam and has worked on many international projects in her various roles at Nike.
Dr. Yen successfully translates basic science to clinical application and has established many fundamental clinical trials in cancer therapy. He has opened a new conversation between Chinese and western medicine in a high standard clinical trial. He also translated nano-particle research into the first human clinical trials, which sets a standard for the future of nano-particle medicine. His research in Ribonucleotide Reductase has been exemplary, from molecular biology to drug discovery. He is a humanitarian that has connected Tzu-Chi’s bone marrow registry in Taiwan with other registries around the world. Therefore, Dr. Yen is a paragon of a true physician.
1. Head of Preparation Committee, Palliative Health Center, Suwaikh, Kuwait, 2010 to date 2. General Secretary, The Gulf Federation for Cancer Control (www.gffcc.org ), 2003 to date; 3. Vice-President, Board of CAN Campaign (Cancer Aware Nation), (www.cancampaignkw.com ), Jan. 2011 to date 4. Founder and Editor-in-Chief, The Gulf Journal of Oncology (www.gffcc.org/journal ), 2007 to date; 5. Associate Editor, Pan-Arab Medical Journal of Oncology, (http://amaac.org/05.htm), March 2008 to date 6. General Secretary, Kuwait Society for Smoking and Cancer Prevention, (1994 to date); 7. Asst. General Secretary, The Arab Medical Association against Cancer (AMAAC) (http://amaac.org), based in Cairo, Egypt. (2007 to date); 8. Asst. General Secretary for Kuwait, The Arab Federation for Drug Abuse Prevention, (June 2006 to date); 9. Chairman, Kuwait Society of Oncology, Nov. 2005 to date 10. Head of Organizing & Direction Committee of the Health Care Hospital at Al Sabah Medical Area in the State of Kuwait, 2011 11. Head of Organizing & Direction Committee of Al Essra'a Oncology Centre in Nables, Palestine, 2008;
Most recently, Dr. Al-Amoudi founded and serves as the chairwoman of the "Women's Health Rights” Scientific Chair at King Abdulaziz University, the first of its kind in the region. She authored the first book in the Arab region on breast cancer in sign language for the 2011 Breast Cancer Advocacy and Awareness campaign in sign language. Last year, she was noted by Arabian Business among the most 500 influential Arabs and ranked 11th among the Arab scientists. She was among the first group of female medical graduates from King Abdulaziz University in Saudi Arabia. Previously, she was appointed Vice Dean of the College of Medicine and Allied Science. Dr. Samia Al-Amoudi is the author of 14 books. She has been recognized through various awards and honors. In March 2007, the U.S Department of State awarded her the first International Women of Courage Award in recognition of her breast cancer awareness campaign and for sharing her personal battle with breast cancer to raise awareness across the Kingdom and throughout the Middle East. Also in 2007, she served as facilitator to the former First Lady Laura Bush for her meeting with breast cancer survivors in Jeddah during her visit to Saudi Arabia. She was honored by Susan G. Komen for the cure in March 2008 in Washington DC. In 2010, she was invited by US vice-President, Joe Biden, and his wife, Dr. Jill Biden, as a Susan G. Komen Global Advocate. Dr. Al-Amoudi is the recipient of the award ALMIFTAHA from Prince Faisal bin Khaled of Asir region in recognition of her work and efforts to raise public awareness on breast cancer. She was also honored by Princess AlAnood bint Abdullah, wife of Amir of Mecca region, Prince Khaled AlFaisal, in 2009 for her dedicated and pioneering work towards her country and her community. Her story was included in the secondary schools English curriculum in 2008 (People Who Made a Difference). A documentary film about her story with breast cancer (Break the Silence) was aired by Al Arabia news TV channel in 2009. She has also participated in numerous print, radio, and television programs, including CNN and ABC Good Morning America.
[email protected] notes
One year of Research Fellowship at the Gray Laboratory, Northwood (London UK). - Chairman of International Conferences (1000 to 6000 participants): Chairman of the International Conference on Innovative approaches in Head and neck Oncology ICHNO (Barcelona, 2007). - Chairman of the 29th European Society for Radiation Oncology Conference (Barcelona, 2010) - Chairman of the ESTRO 30th Anniversary Conference (London 2011)
A partir de 1974, mon expérience professionnelle s’est faite dans le cadre de l’Organisation Mondiale de la Santé au Centre International de Recherche sur le cancer (Lyon – France). Mes projets scientifiques étaient alors sur le lymphome de Burkitt (Programmes en Afrique Centrale, Afrique du Nord, Europe) et sur le cancer du nasopharynx (Chine, Afrique du Nord). A mon retour des Etats-Unis en 1985, j’ai lancé avec le Pr B. PONDER le Consortium International qui a permis la découverte des gènes de prédisposition au cancer du sein, et qui continue à coordonner les actions dans ce domaine. Depuis 2000, dans le cadre de mes fonctions de Directeur de la Recherche, nous avons mis en place, avec le professeur Thomas TURSZ, des programmes européens de recherche translationnelle et lancé le programme international WIN sur la médecine personnalisée. Depuis mon arrivée à la présidence de la Ligue Nationale Contre le Cancer, j’ai souhaité renforcer la politique internationale avec la création de l’Alliance des Ligues Francophones, Africaines et Méditerranéennes (ALIAM), dont je suis le Vice-Président et la participation plus active à l’European Cancer League (ECL) et à l’UICC
Main missions and international collaboration with low and medium income countries: Indonesia: Djakarta et Surabaya French cooperation for lymphoid malignancies 1981 Congo: Brazzaville, Histopathology of HIV infection 1987 Marocco: Casablanca Immunohistochemistry technics, Casablanca 1989 Romania: Bucarest Histopathology of HIV infection 1992 Turkey: Istanbul, Ankara, New classifications of lymphomas 1998 Support for pathological diagnosis with Congo Brazzaville, Democratic Republic of Congo, Mali, Senegal, via telepathology and i-Path, Coordination of the Pathology committee for the GFAOP (Groupe franco-Africain d’Oncologie Pédiatrique) Research exchanges with Algeria, Democratic Republic of Congo, Senegal, Mali. Vice President of the NGO: Alliance Mondiale Contre le Cancer (AMCC) since 2009 Member of INCTR (International network for Cancer research and treatment since 2009 Member of the Team of Pathology program of INCTR
He has been serving for severally years as the chairman of the World Committee of International Union of Leukemia Research and Related Diseases (IICRLRD) and then for quite a period as a secretary of this international organization. He has an excellent background both scientifically and clinically, because he started his scientific carrier in Sol Spiegelman´s laboratory and then created renowned group organizing and supervising European projects related to human leukemia research and therapy. He is excellent in handling scientific project and in keeping in close touch with his scientific colleagues and very efficient in creating and collaborative milieu open to new ideas and expansion of cancer research field both scientifically and clinically. You can easily obtain further information from his colleagues in Germany and from past members of the World Committee.
The focus of both, my scientific and routine work, had been oncology since 1975. In 1987 I was specialising in functional imaging, improvements of tumor diagnostics and therapy management of oncological patients. I like to provide some information about the DKFZ. The German Cancer Research Center is the leading cancer research center and performs research using cutting edge technology at a high international standard. This has been proven by the Nobel prize of 2008, which was received from Prof. Harald zur Hausen, the former head of the center. DKFZ is the national cancer research institute congressionally financed and is leading the academic cancer research in Germany. The Medical PET Center localized in the heart of DKFZ initiated the application of PET in oncology more than 20 years ago and it was one of the first PET Centers in the world operating two PET scanners at that time. During the past decades I have been focusing on studies mainly for monitoring chemotherapy of tumor patients with dynamic PET (dPET) and parametric imaging, and the correlation of dPET with molecular biology, especially based on the use of specific radiopharmaceuticals and gene array data. Furthermore, the design of new radiopharmaceuticals based on in silico modeling techniques is performed since several years and five new tracers are currently in development.
International Experience: I am writing in support of the nomination of Prof. Raphael Catane as a member of the UICC Board of Directors. I have known Prof. Catane for about 15 years. We met while he served as Director of the Institute of Oncology, Shaare Zedek Medical Center in Jerusalem. Our meetings revolved around supporting Jordanian and Palestinian oncologists via training programs and collaborative research projects. Thereafter, I have been visiting his Institute of Oncology at the Sheba Medical Center, the leading medical center in Israel; bringing with me foreign diplomats in order to present them with what we would consider a center of excellence in oncology. Having visited multiple cancer institutes worldwide, I can proudly attest that the institute that Prof. Catane has been leading for the past 20 years would merit a position in most medical centers in North America and Western Europe which are considered to be in the top 10%. Regarding his academic activities, his curriculum vitae (enclosed) clearly demonstrates dedication to clinical and basic research. Many of his publications are considered significant and were published in the more critical journals (all together, 178 publications). At the national level Prof. Catane has demonstrated that he is an excellent clinician, organizer and leader and has a high curiosity about public affairs. Prof. Catane has served as the Chairman of the Israel Society of Clinical Oncology and Radiotherapy since 2005. He is an amicable and considerate person who relates to people very well. Internationally, Prof. Catane (Full Professor at the Tel Aviv University) has been an active member of ASCO for the past 9 years and since 2009 has served as the Chairman of the International Development and Education Award Task Force at ASCO. Prof. Catane was the Founder and Chairman of the ESMO Palliative Care Working Group during the years 1999-2006, and has been serving as the Chairman of the ESMO Ethics Committee since 2008. His vast national and international responsibilities and experiences, which were all carried out in a most successful way, indicate Prof. Catane's qualifications to serve on the Board of a distinguished organization such as the UICC. His greater maturity, motivation and insight are evident in many areas of cancer treatment, prevention, awareness and advocacy. During the course of his career, Prof. Catane spent five years in the United States, four of which were at the National Cancer Institute in Bethesda, MD, which exposed him to modern cancer research including Therapy Evaluation and drug research, which are so relevant for many countries today, especially in the developing world. Prof. Catane not only set up an outstanding Oncology Institute, but has been actively involved in international affairs in the United States and Europe. The latter is in addition to what we would describe as a heavy administrative responsibility. Among the outstanding characteristic qualities of Prof. Catane is his constant search for new ways to improve the quality of his clinical activities. He has attended a diversity of meetings, workshops and conferences, not only to keep abreast of the current work, but to get acquainted with the newest protocols, techniques and the more sophisticated new equipment. I am confident that Prof. Catane will contribute significantly to the UICC's future goals and objectives by joining its Board of Directors.
Fellowships: • Head and Neck Surgical Oncology, Mount Sinai Hospital, University of Toronto, Toronto Ontario, Canada. • Microvascular Head and Neck Surgery and Reconstruction, Sunnybrook Health Science Center, University of Toronto, Toronto Ontario, Canada. • Skull Base Surgery, Department of Maxillofacial Surgery, Plastic and Rconstructive Surgery, Inselspital, University of Bern, Switzerland. Teaching and Visiting Professor in North America, South America, Europe, Asia and Australia. Prof. Fliss is also the recipient of the Honour Award of the American Academy of Otolaryngology Head and Neck Surgery (2006) and of the prestigious Eugene N. Myers International Lecture on Head and Neck Cancer (2008) at the American Academy of Otolaryngology Head and Neck Surgery in Chicago. He is an Invited Traveling Faculty for the 2012 World Tour Program of the International Federation of Head and Neck Oncology and Surgery, and a Councilor of the International Academy of Oral Oncology (IAOO). Editorial Board Member: • Head and Neck. • Skull Base An Interdisciplinary Approach – Section Editor - Head and Neck Oncology. • Otolaryngology Head and Neck Surgery. • European Archives of Otorhinolaryngology and Head and Neck. • Oral Oncology • Auris Nasus Larynx (ANL) • The Journal of Surgical Techniques in Otolaryngology, Head and Neck Surgery. • International Journal of Head and Neck Surgery • Otorhinolaryngology Clinics. Review Board of other 10 journals. Invited Guest Lecturer in Australia, Albania, Brazil, Bulgaria, Czech Republic, Croatia, China, Chile, Canada, Denmark, Egypt, France, Germany, Greece, Hong-Kong, Holland, India, Italy, Kossovo, Korea, New Zealand, Mexico, Serbia, Switzerland, Spain, Singapore, Turkey, Taiwan, USA, Vietnam, Russia
[email protected] One-year research experience in NIH, US.
Email address Summary of International Experience
[email protected] or [email protected]
Candidate at the Management Board of the European Medicine Agency (EMA) Member of the Union of International Cancer Control (UICC) Member of the European Cancer Patient Coalition (ECPC)
After long consideration I came to the conclusion that as a long-term Chairman of Chair and Department of Medicine & Endocrinology , Warsaw Medical University and long term National Consultant in the field of Endocrinology I have been obliged to deal with broad problems of cancers of endocrine glands and neuro-endocrine tumors. In addition part of my research was concentrated on the molecular events that can lead to the cancer formation or affect the clinical course of cancer. Finally I am MD for years and physician nowadays see many cancers as they are quite common Therefore I came to the conclusion that I can make proposal and I would like to support Prof Barbara Jarząb MD, PhD as the candidate for the Board of UICC Directors .
“Improving stoma care and site”, Trish Greene International Oncology Nursing Fellowship Award from the International Union Against Cancer (UICC) supported by the Oncology Nursing Society (USA), The ONS Foundation, The Oncology Nursing Services and The Oncology Nursing Certification Corporation. H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA, July-Auguste,2006 2000. ESMO Budapest, Hungary Certificate of participated in the course on PALIATIVE CANCER CARE from 8-10September 2000. The number of credit point for the ESMO-MORA category 1 is:19 1998. ESMO Ouranoupolis, Hellas Certificate of attending at 8th European Interuniversity Simposium from Clinical Resarch to Standard Practice 1996. European Congress of Enterostomal Therapists Rotterdam, Netherlander 1992. College of Midwifery Dorset and Salisbury, United Kingdom Certificate of the Successful Completion of ENB Course 980 "The Principles of Stoma Care"
Marilyn Gentry is one of the founding members of the WCRF global network. Under Marilyn’s leadership, the WCRF global network is responsible for helping transform public opinion that cancer is simply a matter of genetics or bad luck. In the early 1980s when Marilyn began her work, nobody spoke about cancer being a preventable disease and ours was a lone voice. Today, thanks to Marilyn’s vision and determination, she leads a thriving global network of cancer charities that collaborate with key institutions and organisations around the world to promote science-based changes to reduce cancer risk. It was Marilyn’s visionary thinking which led to the development of three evidence-based, global Expert Reports on food, nutrition, physical activity, body fatness and cancer. As a result, millions of people across the world are now aware that cancer is largely preventable, and that there are positive steps everyone can take to help reduce their risk. Marilyn has experience of many global partnerships and initiatives. Over the last three decades she has attended leading global for a, such as United Nations and World Health Organization meetings. In the past, the WCRF network members and/or WCRF International have, under Marilyn’s leadership, partnered or collaborated on projects with varied entities, including FAO, INCA, UNICEF, WHO, PAHO, the Hong Kong Department of Health, as well as national organisations such as Breast Cancer Care in the UK, just to name a few. In addition, every year the WCRF global network supports the UICC World Cancer Day by ensuring we have an internationally coordinated response across our network. Marilyn shares UICC’s goal of eliminating cancer as a life-threatening disease for future generations. She has inspired the WCRF global network to become a leading international player in the vital area of cancer prevention research, health information and policy. Our network’s commitment to funding scientific research into the links between lifestyle and cancer, to positively influencing key decision-takers around the world, and to giving people the information they need to make informed choices is testament to Marilyn’s drive and dedication to a future free from cancer. The UICC Board would be enriched by the energy, motivation and wealth of experience that Marilyn would bring to help the organisation achieve its goals. As Marilyn has continued her crusade to ensure that the public is made aware of the diet and cancer prevention link, and that governments, individuals, and workplaces take responsibility for actions to prevent cancer, her international policy work has come to the fore. Marilyn represented the WCRF global network and cancer prevention by attending the United Nations High-Level meeting on Non-Communicable Diseases in New York in September 2011. This represented a once-in-a-lifetime opportunity to mobilise the world to take action to reduce rates of cancer and other NCDs. WCRF International also chaired an expert working group on nutrition, physical activity and NCD prevention on behalf of the NCD Alliance in support of activities around this event. Under Marilyn’s leadership, the WCRF global network is committed to promoting and supporting the resulting Political Declaration. Marilyn has a well-earned reputation for her integrity and for standing firm to her principles. Again and again in the history of the WCRF global network, Marilyn has made the tough decisions and influenced our staff to make the right choices to take our mission further. She is a wonderful and inspiring leader, who motivates our team of 130 people around the world with her dedication and commitment to WCRF’s mission. Marilyn is a team player and has a keen attention to detail. She is truly an international citizen—calling both the USA and the UK home. Marilyn has the full backing of WCRF International in this endeavour and is committed to making the time to attend meetings, fundraise, and otherwise help to ensure the work of the UICC board leads the organization. I cannot think of a more ideal representative for your board.
I am the National Project Coordinator, Bangladesh Chapter of IAEA, and member of American Society of Clinical Oncology (ASCO). I finished my Doctor of Medicine (M.D) from Donetsk State Medical Institute, Ukraine (The Then USSR) in 1982 and then got Post graduation Training on Gastroenterology up to 1983. I got higher training in Oncology from UK, France, China, Singapore, India, Sweden, Netherlands, Germany, USA, Italy and Malaysia.
Coordinating International collaboration between the TMH and major institutes internationally namely – MDACC, Huston, Texas and Harvard University, Mayo Clinic, etc. Current president, Asian Society of Head & Neck Oncology as well as Convenor from India for International Federation of Head & Neck Oncological Societies. Visiting professor and invited guest to many international institutions such as MDACC, University of Southern California, University of Louisville etc. Major speaker at majority of international meetings on Head & Neck Oncology. Awarded Honorary FRCS, Royal College of Surgeons, England for contribution to the field of surgery.
Lance Armstrong Foundation’s Summit of World Cancer Leaders Dublin, Ireland 2009 20th World Cancer Congress Geneva 2008 19th World Cancer Congress Washington DC 2006 3 GCCO (Presented 2 papers) Brighton (UK) 2001 Fellowships APCASOT training Brisbane & Melbourne, Australia 2002 Fellow and Life Member of the Union for International Cancer Control (UICC) American Cancer Society University Chennai 2005 Alumnus American Cancer Society University (ACS) In February 2002, Mrs. Govil was awarded a fellowship for studying the Australian Model of Cancer Societies in Brisbane and Melbourne, Australia, under the APCASOT scheme of UICC, and subsequently made a Fellow and Life Member of the International Union Against Cancer (UICC). She is an alumnus of the American Cancer Society University (2005) and was invited to attend the World Cancer Congress in July 2006. Her paper on Volunteerism has been accepted for publication at the World cancer Congress, Geneva (August 2008). She was selected to be one of only 500 of the World’s Cancer Leaders in August 2009, at the Livestrong Conference in Dublin, Ireland.
[email protected] or [email protected]
Fellow of UICC, Visiting consultant to many well known international academic and research centres, active member of American Association for Cancer Research, Third world country womens organisation , International Academy of Pathologists, peer reviewer few well reputed Internal Oncology journals
1. Since the year 2000 I was appointed to be a coordinator for Indonesian Ostomy Association under the auspices of the Indonesian Cancer Foundation, and followed a stoma training at a hospital in Modena, Italy for a week. Most of Indonesian Ostomates are colorectal patients. I learned about stoma care and stoma appliances that was very important for ostomates, as their quality of life would be better. 2. In the year of 2010, my abstract was accepted at Asian Oncologist Summit event (for a poster session) 3. As a General Secretary at the 6th Asian Society of Stoma Rehabilitation Congress held in Jakarta. The congress host was the Indonesian Cancer Foundation. 4. Followed several palliative trainings and stoma congress in Singapore and Malaysia
I participated UICC congress in 2002,2006, and presented papers.I am the council member of Asian clinical oncology society and execytive member of SAARC Federation of Oncologist Nepal.I am Training Director of the WHO in Nepal. As a executive central member of Nepal Cancer Relief Society, only NGO working in the field of Cancer and member of UICC, actively contributed in signing and ratifying FCTC in Nepal.
1. Participated in Numerous Scientific conferences. 2. Worked as the Chairman of SAARC federation of Oncologists for 8 yrs and now Patron of the organisation for 2 years.
Attended ICC 4 International Congress in South Korea. Attended two year training in Counseling of the Certificate of Counseling and Care Centre Singapore in 2010. Attended Certificate in Cancer Counseling Training Programme of Tian Jing Medical University, China, conducted by Professor Xishan Hao, MD. FACS. Attended International Cancer Control Congress - IV in South Korea. Attending Advanced ASCO – MECC International Development & Education Course in Palliative Care, Ankara Turkey from April 2012
Her unit, Cervicare, has hosted as well as mentored providers and trainers from Laos, Cambodia, Myanmar, Vietnam, Philippines as well as providers from developed countries who are interestetd in VIA and Cryothwerapy. She has been invited to conduct training of providers and trainers in via and cryotherapy from within the region (eg. Vietnam) to as far as Uganda. She is a committee leader and/or member of a variety of regional professional organizations such as the Menopause society, Streering Committee on Safe the Mother initiaitive of the FIGO, South East Asia Regional Association of Medical Education as well as the executive committee of the World Federal Medical Education.
Union for International Cancer Control, Geneva 2002–current: Chair, Asia Pacific Cancer Society Training Grant Program (APCASOT) 2009-current: Chair, Capacity Building Fund 2009–current: Chair, Reach to Recovery International 2010-current: Member, World Leaders Forum 2011-current: Member, McCabe Centre for Law and Cancer Advisory Committee LIVESTRONG 2007–current: Member, Global Campaign International Advisory Committee International Psycho-Oncology Society (IPOS) 2010–current: Invited Director, Board member Psycho-Oncology, The Journal of the Psychological, Social & Behavioral Dimensions of Cancer 2006-current: Member, Editorial Board Cancer Council Australia 2002-current: Member, Chief Executive Officer (CEO) Forum Clinical Oncology Society of Australia (COSA) 2000-current: Member Cancer Forum: Journal of The Cancer Council Australia 2000-current: Editorial Panel Queensland University of Technology: Faculty of Health Advisory Committee 2010-current: Member Australian Institute of Company Directors 2010 current member. Experience with the Union for International Cancer Control My formal UICC association commenced in 1993 at the APCC meeting in Bangkok where I was appointed to, and ran workshops for, the COPES (Campaign, Organisation, Public Education and Support) Regional Coordination Project, Asia Pacific Team.
Asian Advisory Board for Eribulin in Breast Cancer for Eisai 2010. Advisory Board GlaxoSmithKline on Pazopanib 2010. Advisory Board Novartis 2009. Scientific Committee for 20th Asia Pacific Cancer Conference (APCC) for 2009. Scientific Committee for Asia Pacific Oncology Summit (APOS) for 2009. Editorial advisor for Oncology & Haematology News Elsevier from 2009. Member of Lilly Oncology Advisory Board 2009. Advisory board member for GlaxoSmithKline on Lapatinib : 2008. International advisory board member for Pfizer on Sunitinib from 2007. Clinical Trials committee in the South East Asia Radiation Oncology Group (SEAROG) from 2006. International advisory board member for Bayer Pharmaceutical on Sorafanib from 2006. International advisory board for Schering AG for Bonefos 2005. International advisory board member for Astra Zeneca on breast cancer 2005.
On the international level, she is a member of the Asia-Oceania Federation of Obstetricians and Gynecologists (AOFOG) Young Gynecologist Awardees Network; Member, International Gynecologic Cancer Society (IGCS); Member, International Society of Cervical Pathology and Colposcopy (ISCPC), Member, AOGIN Asia and Program Director of CECAP (Cervical Cancer Prevention Network Program) in collaboration with JHPIEGO, an affiliate of John Hopkins University. She has been tapped as technical expert in both national regional technical meetings under the auspices of WHO regional office.
My involvement in tobacco and cancer control control goes back to around 1995, when together with other colleague (Ronaldo Luna, M.D.) founded the department of prevention at the National League against Cancer, and started an intense and organized work for tobacco control through public education and developing activities to influence and provide technical and scientific advisory to national institutions in order to promote and properly orient their activities in this area. At that time, the National League against Cancer became a member of the International Union against Cancer (UICC), and a few years later I was elected to be a member of the Executive Council of UICC, position that lasted for four years, and permitted to obtain full cooperation of this organization for the work being developed in Guatemala, for tobacco control and other areas of cancer prevention. In 1998 I became Dean of the Faculty of Health Sciences at Landivar University in Guatemala, and from this position it was possible to obtain a generous financial cooperation from the American Cancer Society, to continue and expand the work for tobacco control in Guatemala. Around the year 2000, with the technical cooperation of the Pan American Health Organization, we founded the “National Council for Tobacco Control”, with the participation of 15 institutions, including Universities, NGO´s dedicated to cancer and cardiovascular prevention and care, Ministries of Health and Education, PAHO, and others. This council was very active in lobbying the National Congress, first for the approval of the International Framework Convention for Tobacco Control, and later for the approval of the law of “Tobacco free environments”. Since 2005 I am coordinator of the Division of Tobacco Control at One Voice against Cancer. That same year we applied and received two grants from the “Campaign for Tobacco Free Kids”, one in support of the actions to have the law for “Tobacco free environments” approved, and the other to support studies, actions and lobbying for a law to include pictograms in all tobacco packages. This law is now being discussed at the National Congress. Also, around 2006, with the financial cooperation of the American Cancer Society, we organized a Central American workshop, to promote and support the creation of national groups for tobacco control in the Central American countries; and later visited El Salvador and Nicaragua to work with groups interested in this matter. At present time we are working for the creation of a National Network for Tobacco Control (RENACTA: Red Nacional para el Control del Tabaco), have created a web page at One Voice against Cancer, with one section dedicated to tobacco control, and participate in multiple national activities with the Ministry of Health, other government institutions and many educational establishments for tobacco control. In addition to tobacco control, I have also worked intensely on cancer prevention, having collaborated on the UICC manual for cancer prevention as one of the authors, and have trained many groups on cancer prevention. I believe this is one of the cornerstones of public health, as well as a priority for Guatemala and other developing nations. My pathology training gives me a omplementary background in the cancer control field. My past experience as an active member of the National Cancer League allows me a good insight into the needs of cancer hospitals are them public or private.
[email protected] Under Dr. Bal’s leadership in the State of California, where he served as the Chief of the Cancer Control Branch within the Department of Health Services for over two decades, some of the most innovative, globally recognized public health policies were established. With the advent of Proposition 99, which added a $.25 tax on each package of cigarettes sold in California, he became responsible for implementing California’s tobacco control efforts. This tobacco use prevention and cessation program is one of the largest of its kind in the world and has been universally acclaimed for its innovations and effectiveness. He is the founder/director of California’s Tobacco Control and Obesity Control efforts. His branch budget was in excess of 250 million dollars. In this role, Dr. Bal also had leadership and oversight of the California Cancer Registry, the Cancer Prevention and Nutrition Program, the Cancer Detection Section and Tobacco Control Section, the Cancer Planning, Research and Disparities Program, and the Skin Cancer Program. Over the past two decades, he has had a long-standing and close association with the National Cancer Institute. In addition to having been the Principal Investigator on a major NCI grant, he has served on numerous NCI advisory groups, work groups, PRG’s and study sections (including as Chairman). He has a good working relationship with individuals at every level of NCI and has been a co-author and reviewer on several scientific Surgeon General’s and NCI Reports. Dr. Bal has worked extensively on Cancer Prevention, Control, and Research with many other organizations, including the Centers for Disease Control, the Robert Wood Johnson Foundation, the Rockefeller Foundation, the California Endowment, and others. He has been a reviewer of scientific reports on cancer prevention, control, and research, for the Institute of Medicine of the National Academy of Sciences and has testified at their hearings. He is well published in the medical literature, especially in the area of cancer. He is a frequent scientific reviewer for the Journal of the American Medical Association, Cancer, and other medical journals. He is also a sought after international speaker on cancer. Dr. Bal has also played instrumental planning roles in major global conferences, including the World Conference on Tobacco OR Health, where global leaders and experts convene to advance the fight against tobacco. Within the American Cancer Society, over the past 31 years, Dr. Bal has held every conceivable office for which physicians qualify, including service as our National President (2000-2001). He has chaired the Prevention Committee at ACS National, the Professional Education Committee in California Division, the Committee on Cancer and the Underserved at ACS National, and the Scientific and Medical Affairs Committee at ACS National. He has over the years worked effectively at the grassroots, state, and national levels, and been the President of the Sacramento Unit, the California Division, and most recently has been our National President for this past year (2000-2001.) He is very knowledgeable about cancer prevention, control and research at the national level and has represented the Society at many national and international forums. He is an accomplished speaker who has the ability to make some of these complex cancer control issues user-friendly for even lay audiences.
I would summarize my international experience from two aspects; First: academic experience and second NGO experience Academic experience: I spent two years at MD Anderson Cancer Center as a Fullbright Scholar, I have involved in many international events and projects during the last 30 years at Hacettepe University. I have been members of professional organizations including SIOP, ASCO, AACR and others. I organized Cancer Registry panel and also chaired sessions at SIOP meetings. I represented Hacettepe University in many international events and recently coordinated the relation of the University with a US institution and R&D agreement. I had served as the director of Oncology Hospital and Oncology Institute and involved at international relations of this organizations more than 10 years. NGO experience UICC involvement: I have been working very closely with UICC and served at Membership committee (member, then chair), Strategic coordiationg committee, strategic advisory committee, Task force for Auspices (chair), Task force for Awars, My child matters steering committee, Global Cancer Control community, world cancer declaration working group, World Cancer Day activities, expert panel for cancer organizations for eastern Europe, World Cancer Congress committees, UICC reel lives film festival jury member and others. Additionally I have chaired many UICC collaborated national activities in Turkey including Hope Lodge Project, Cancer Patient Forums, UICC capacity building project, World cancer acivities, translations of UICC resources, Turkish TNM Committee and others. European Cancer Leagues involvement: ECL is a umbrella organization for European Cancer organizations (around 30 member society). I had served as a boar member and treasurer for 4 years then served as the president during 2002-2011 for two years. During my presidency, ECL had involved in European Partnership for Action Against Cancer (EPAAC), a EU initiated Europe wide project. ECL is still leading the prevention package of that project and I represented ECL in meeting at EU parliament building and involved in many different ECL actions and events. This was a very exiciting work for me and I was able to contribute to ECL work in many ways. ECCO advisory council membership: I represented ECL in ECCO advisory board for two years. This was also a unique platform for sharing the knowledge and expertise. IPA (International Pediatric Society) environment committee: This is the largest international pediatric society and I am a member of this committee. International Children’s Center: This center was established in France and its management was in Turkey since early 90s. I am a council member of ICC. It is mainly developing international projects on childhealth.
During Prof. Tuncer's tenure in the Ministry of Health he succeeded in achieving solid international work relationships with regional organizations, i.e., The Middle East Cancer Consortium and International organizations such as the Asian-Pacific Organization for Cancer Prevention, and IARC. As such, Prof. Tuncer provided himself with a clear and succinct vision of issues related to Cancer Control globally. Throughout his tenure in the Turkish Ministry of Health he persistently advocated for international collaborations and mutual support in campaigning against cancer. An important reason for his success in the international arena is his diplomatic talent and manners while negotiating with colleagues, politicians, administrators and legislators from foreign countries. Prof. Tuncer could not have achieved his governmental goals and objectives without having built a coherent, professional and competent team. Again, his personality enabled him to achieve excellent inter-human rapport and relationships, both nationally and internationally. Recently, Prof. Tuncer was nominated to be the Rector of Hacettepe University in Ankara, Turkey, the most prestigious academic institute in that country. The nomination was made by President Abdullah Gül, President of the Republic of Turkey, following elections by the academic staff of that University. The latter nomination, the highest post for an academician, was preceded by his position as the Chairperson of the Department of Cancer Control in the Ministry of Health (2001-2011), Chairperson of the Department of Pediatric Oncology, Hacettepe University Hospital, Ankara, Turkey (2004-2007), Director, Hacettepe University Pediatric Research Center (2000-2004), Director, Institute of Child Health, Hacettepe University (1993-2000), Director of Hacettepe Children's Hospital (1992-2000) and he obtained full professorship in Pediatrics and Pediatric Hematology in 1995. Concomitantly, Prof Tuncer gained a National and International reputation through his involvement in leadership roles in professional societies such as the Asian-Pacific Organization for Cancer Prevention and the International Agency for Research in Cancer. All of the above achievements: academic, clinical, administrative, and organizational, clearly indicate the outstanding performance that has lasted for more than a decade. Further, Prof. Tuncer serves as the leader of the Turkish "New Hope in Health Foundation" which exposes him to the public media, pharmaceutical companies and fund raising. During his tenure in the Ministry of Health, Prof. Tuncer became extremely involved in an anti-smoking campaign. When Prof. Tuncer, representing the Republic of Turkey, joined the Board of Governors of the Middle East Cancer Consortium (MECC) in 2004, I was pleasantly surprised and pleased by many of his personal and professional qualifications. Not only had he already achieved a full professorship in Pediatrics and Pediatric Hematology and Oncology, but he also had the experience of administering a ministerial department of cancer control. During our work together, Prof. Tuncer succeeded in building and operating a network of cancer registries in 8 provinces in Turkey. Moreover, our fruitful work together yielded the development of cancer palliative care services in Turkey through ongoing training activities which resulted in the "opening' of the oncology services for opioids. Since 2009, Prof. Tuncer has been serving as the chair of MECC's Board of Governors; and right from that time, it became clear to me that Prof. Tuncer was not the usual "national representative". His greater maturity, motivation and insight were evident in many areas of our joint work. His special interest in advocacy and public awareness, along with clinical and scientific affairs took us into several optional areas such as the establishment of a new international professional journal which is already in advanced stages of creation. Through my repeated visits to Turkey and our collaborative work in Europe and the United States, I learned that Prof. Tuncer not only set up an incredible active department in the Ministry of Health, but he has stimulated and encouraged many colleagues and associates in various aspects of cancer control in his own country and outside it. If there is one outstanding characteristic of Prof. Tuncer which impresses me more than any other, it is his constant search for new professional experiences to improve and promote issues related to cancer control. When one compares Prof. Tuncer's experiences and accomplishments with those of other potential candidates for the post of the UICC President Elect, I have no doubt in my mind that he ought to be considered as a serious candidate. Prof. Tuncer has expressed a strong interest in this post and is willing to devout his time, energy and international contacts for the overall goal of the UICC. I feel that in order to be eligible for such a position, a candidate must have demonstrated substantial accomplishments in clinical, administrative, academic, and public affairs. I am convinced that Prof. Tuncer has successfully fulfilled these requirements, and therefore I wholeheartedly support his candidacy. With the proper support and encouragement of the UICC staff and his dedicated efforts, I would predict a most productive future in his contribution to the UICC's global objectives.
[email protected] Dr. Chen received his early medical education in China, then obtained his doctorate degree from The University of Paris VII in France, and went for further research in New York of USA. His brilliant research involves diverse international collaborations. Over the years, Dr. Chen's basic and clinical findings have profound international influence. This is at least partly reflected by his honors being awarded, like The China National Grand Prize for Scientific Research, his membership in The National Academy of Science of USA, the US Institute of Medicine, and The French Academy of Sciences, the Third World Academy of Sciences, and the European Academy of Arts, Sciences and Humanities. During his tenure as Vice President of the Chinese Academy of Sciences, Dr. Chen was responsible for overseeing international cooperation and biomedical technology. As minister of The Ministry of Health of P. R. China, Dr. Chen spoke frequently during international meetings like WHO to address both national and international issues relevant to human health, including the concerted prevention, diagnosis and treatment of cancer. Particularly, the quality of Dr Chen's service and leadership during 2004-2006 as co-chairman for IAP, the global network of academies, has been testified by his re-election to this important position from 2007-2009. (http://www.interacademies.net/About/Committees.aspx). Dr. Chen speaks very fluent Chinese, English and French. This lends him instant acceptance by many international scientific bodies and scientists, clinicians, general populations in different regions.
Motivation notes CV NominatorSelf-nominationSelf-nomination
David Makumi Kinyanjui
Dr. Emmanuel Nna
Self-nomination
Willingness to continue
Mrs. Thaís Soares - FEMAMA
Self-nomination
Ms Jessical Hill
Dr. Felicia Knaul
INEN - self-nomination
Dr Larry Corey, Mr Doug Pyle
Ms. Ann McMikelMr Doug UlmanProf. Jonathan Finlay
Ms. Ann McMikel
Prof. Hans-Olov Adami
Dr Kathy A. Masson
Willingness to continue
Prof. Chang Ming Charlie Ma
Dr. Enriquito R. Lu
Maha Hussain, MD, FACP
Self-nomination
Dr. Felicia Knaul
Self-nomination
Dr Erica Alston, Emory University
Self-nomination
Mr Doug Ulman
Willingness to continue
CV Self-nomination
Self-nomination
Willingness to continue
Mr. Michael Bautista
Dr. Felicia Knaul
Dr. Sawsan Al Madhi
CV Prof. Hendrik Van Poppel
ESTRO - Ms Charlotta Nestén
Dr Marc Keller & ALLIAM members
INCA - Prof. Agnès Buzin
Dr Jan Slovboda
Prof. Ulrich R. Kleeberg
Self-nomination
Prof. Michael Silbermann
Self-nomination
Voluntary and solidarity with the cancer patient, my fiancée and in Oncology prepares the thesis "The cancer in the elderly" to be a professor of oncology, so my personal life and family will always support and awareness against this illness.
I am confident that my background and experience as Medical Doctor and person involved in mobilization for the prevention of non transmissible diseases, especially cancer, in D.R. Congo is suitable match for your needs. I have worked for three years as a Medical officer at Kitsombiro Reference Health Centre, in the rural health zone of Lubero (Creating cancer awareness in the health zone and in Kitsombiro church district, creating awareness, planning and implementing Kitsombiro cervical cancer screening centre, Training the personnel and community animators on cervical cancer in Lubero Health Zone. I currently work as a President of MEDECINS UNIS EN MISSION, an organization which is a member of UICC. It is a recognized organization involved actively in fight against cancer in Eastern part of D.R. CONGO. I have participated online to many forums in global exchanges about cancer. And I am ready to deliver my experience in the board of UICC if this position is offered to me. In conclusion, I am confident that if considered for this position, I will make a very positive impact to UICC, our organization. CV
Mr.David Makumi Kinyanjui was the first nurse from Africa to be awarded the International Award for Contribution to Cancer Care in 2011. He is a nationally respected passionate volunteer advocate who has used the global platform effectively through his numerous international speaking engagements to highlight cancer issues in developing world. A team player per excellence, His integrity is beyond question. CV
v Professor of Radiology, College of Medicine, University of Nigeria Nsukka and University of Nigeria Teaching Hospital Enugu(UNTH), AND ASHOKA FELLOW v Chairperson, Association for Good Clinical Practice in Nigeria(AGCPN), www.agcpn.org v Chairperson, 'Breast Without Spot' Initiative, http://www.breastwithoutspot.org/ v African Coordinator of CITI (Collaborative Institutional Training Initiative of Univ. Of Miami ) v INITIATOR, All Youths Against Cancer/NYSC Cancer Prevention Advocates/BWS Cancer Prevention Clubs in Secondary Schools, and also the 1)Annual International Cancer Week in Nigeria. (started 2009),2) Annual Youth Jamboree on every World Cancer Day in Febuary, to sensitize youths to choose healthy lifestyles to reduce their risks to non-communicable diseases later on in life. CV
In year 2000, I attended the advanced leadership seminar in Singapore and created an impact during the event. In year 2004 to date, I have supervised over 12 university graduates during the public expenditure trading survey organized by the Ministry of Finance. In year 2006 have successfully implemented Hiv/Aids prevention/control palliative care practices supported by help the Hospices UK. In year 2006 to date financial secretary West Africa civil society forum. During 2007 general election, I was one of the observers and during that time, I monitored the election objectively. In year 2009 I attended the African Organisation for research and training in cancer based in South Africa (Aortic) conference in Darussalam. I made meaningful contribution during the conference in year 2011; I also attended the Aortic conference in Cairo and also participated during the different presentations. I am also a member of African Advocacy cancer Network that was formed during the conference headquarters in Florida USA. I have successfully implemented several focal and international projects and more so I have chaired several meetings. In year 2010, I successfully organized the Global cancer awareness campaign supported by the max foundation USA. In year 2011, I also successfully organized cancer life celebration for kids supported by the max foundation USA. I am currently engaged in raising awareness in cancer by doing presentations in institutions. CV
Please be advised that if given the opportunity I would like to continue to serve on the UICC Board. To me it is a great honour and privilege to serve as a board member in such an international organization
As President of Femama, The Brazilian Philanthropic Breast Health Federation, founder of ULACCAN, The Latin American Cancer Coalition, I would like to express my desire to become an UICC Board Member, and therefore to represent our patients groups on an international level. In addition, through my expertise and leadership at Femama I would be able to carry out the UICC's message throughout Brazil. I strongly believe that as patients do not have conflicting interests, their voices and points of view are the most important views for international cancer movements. I am a 20 year veteran in the fight against breast cancer and advocate in Brazil and I can bring the UICC into closer contact with our civil society and its movements by supporting its advocacy efforts on a national level in Brazil. The UICC would also be able to bring its issues and messages to other Brazilian grassroots committees in which I participate as well. In both scenarios I can provide the UICC with objective and practical ideas and projects. As a cancer and breast health professional and advocate, It would be an honor to become one of the UICC Board Members. CV
It has been an honor and a privilege to work as a UICC Board Member since I was elected. The challenges and results that have been built constitute opportunities to UICC growth. More recently, UICC name change to Union for International Control produced even more recognition as a strategic and fundamental stakeholder in world cancer control. Also its professional management, the roadmap construction and administration, the regional and local initiatives in the world, the United Nations participation and collaboration on NCDS build the recognition of a work well done.
Dr. Bryant is a national/international expert in cancer control, having been a VP of Population Health and CIO of the Alberta Cancer Board for many years, prior to joining the Canadian Partnership Against Cancer when it was inaugurated in 2007. She has contributed to and chaired many national multi-disciplinary committees in cancer control, screening, and research, and has served in several international roles as well. Dr. Bryant is a strong collaborator and excellent communicator, and is frequently asked to speak nationally and internationally on cancer control issues. CV
Dr Carlos Vallejos is a medical oncologist, researcher, and teacher whose brilliant career has been highlighted by great social sensitivity. The recipient of many awards and distinctions, he has occupied senior executive positions in the field of public and private health in which he has clearly demonstrated a high level of commitment to the prevention, early diagnosis and treatment of cancer. His keen desire to improve accessibility to early, effective cancer care for the needy has motivated him to be a successful leader in this field. He made significant contributions to the cancer prevention and treatment program, Primer Programa Nacional de Prevención y Control del Cancer, prioritizing the five most common malignancies in Peru – cervical, breast, stomach, prostate, and lung cancer, placing the country in the forefront in Latin America, ahead of the Program Against Breast Cancer in Brazil. The replication of Centers for Prevention and Diagnosis in the Ministerio de Salud care facilities that under the slogan “ Prevention to Live” perform screening tests and early diagnosis in order to ensure the well-being of the population, the implementation of cancer units in hospitals around the country, the decentralization of specialized cancer care, and make social inclusion in health, as well as the creation of the Institutos Regionales de Enfermedades Neoplásicas del Norte y del Sur and Peru´s incorporation in The Global Plan to Stop TB 2006 – 2015. His high spirit of innovation led him to be the mastermind and founder of the only prepaid private type system in Latin America specializing in the management of cancer coverage programs by expanding the population´s access to treatment of this disease at low cost, with high-quality care, achieving a 5 year survival of over 66% compared to the achievements of the developed countries. Clearly, these qualities and the abundant evidence of his high capacity in management, his social responsibility and unfailing adherence to research and continuous improvement, categorize Dr. Vallejos as a top health care executive. His innovative proposals will greatly contribute to the changing global environment CV
On behalf of the Fred Hutchinson Cancer Research Center ("Hutchinson Center"), herewith, I am pleased to write this strong LETTER OF SUPPORT for the nomination Dr. Benjamin 0. Anderson to the Union for International Cancer Control (UICC) Board of Directors (BOD), for the period 2012-2014, as put forth by the American Society of Clinical Oncology (ASCO). I believe that Dr. Anderson admirably meets and exceeds the high standards far participation in this critical position, as defined in the UICC BOD Terms of Reference. Dr. Anderson is the Founder, Chair and Director of the Breast Health Global Initiative (BHGI) and Full Member at the Hutchinson Center within the Division of Public Health Sciences, Director of the Breast Health Clinic at the Seattle Cancer Care Alliance, and Professor of Surgery and Global Health Medicine at the University of Washington in Seattle, Washington. The Hutchinson Center, a pioneer in cancer research and home to three Nobel Laureates, has a global goal of creating scientific partnerships for collaboration. Over the past decade, Dr. Anderson has been a leading voice in the international breast cancer clinical improvement and best practices movement through the establishment of the BHGI, a global alliance of organizations and individuals dedicated to improving health outcomes of medically underserved women, co¬sponsored by the Hutchinson Center and Susan G. Komen for the Cure. Through his leadership, the BHGI has pioneered development of comprehensive resource-sensitive, evidence-based clinical guidelines to improve breast cancer outcomes in law-and middle-resource countries. Throughout the innovative BHGI global work, Dr. Anderson has demonstrated remarkable vision, and gained wide-ranging experience in international cancer control, interacting with the UICC on a range of issues that speak to his suitability for board membership. Over the last six years, through the Hutchinson Center organizational membership in the UICC, Dr. Anderson has served as our official representative. The Center's membership is listed in all UICC directories as "Breast Health Global Initiative/Fred Hutchinson Cancer Research Center." And, reciprocally, the UICC has been closely aligned with the BHGI as a 'Participating Organization,' within the BHGI alliance; in this same time period. The "Breast Health-Common Interest Group" (BH-CIG), launched in 2009 by BHGI in alliance with the National Cancer Institute Office of International Affairs and UICC, was the UICC's first "Common Interest Group," a concept introduced by the UICC BOD to create a common venue for individuals and organizations with interests in global cancer control issues. Last year, in recognition of his global leadership, Dr. Anderson received the ASCO Partners in Progress award, which recognized him as a person involved in activities that impact public awareness about cancer, its causes, cures or treatment, or activities that support, either legislatively or fiscally, cancer research, treatment, prevention or care, and commitment to women worldwide, and his efforts to improve their quality of care. Dr. Anderson has a global perspective towards cancer control and prevention, fully capable to participate at the leading global forums such as the United Nations, World Health Organization and World Economic Forum. He has experience in leading an innovative global initiative, in partnership with other public and private sector organizations in the health field. In my judgment, Dr. Anderson is a proven global leader in the global cancer community, with global vision and exceptional capacity as a team builder, highly regarded internationally amongst peers. I believe that he would dedicate himself to the exceptional global leadership opportunity of the UICC Board of Directors. I recommend him wholeheartedly, and without reservation, for consideration of the UICC General Assembly, schedule in August of this year in Montreal, Canada, prior to the UICC World Cancer Congress.
CV
While cure rates for children with cancer in developed countries now exceeds 75-80%, this amazing statistic is only true for approx. 15% of the children of the world. Dr. Finlay's increasing involvement in and commitment to the children of low and middle income countries over the past 15 years reflects his recognition of the moral obligation of cancer leaders in developed countries to increasingly commit their support and expertise towards improving outcomes in developing countries. CV
CV
I find Dr. Holmes uniquely qualified to join the Board of Directors because she has a long background as a practicing physician before she began a career as a cancer epidemiologist, took a doctorate in epidemiology at Harvard School of Public Health and worked at the Channing Laboratory on the Nurses' Health Study. Dr. Holmes work has been particularly focused on breast cancer research and more recently she has made seminal discoveries with regard to the influence of lifestyle factors on breast cancer survival. Hence, she combines a solid medical background with a profound methodologic training and extensive experience in cancer research and control. CV
Dr. Janjan has previous experience working with Dr. Eduardo Cazap from their leadership activities at ASCO. During her Presidency of ASTRO, Dr. Janjan represented this society at the UICC. She has contributed to numerous projects with the UN/IAEA such as a technical document entitled “Palliative Radiotherapy”. Furthermore, a position on the UICC BOD requires an understanding of geopolitical issues as they impact local healthcare systems. Her work as a Senior Fellow at the National Center for Policy Analysis contributes to her expertise in this regard. CV
It has been an honour to serve UICC and would like to stand for reelection and continue this service. I am aware of the commitment and will continue to devote myself to the tasks of strengthening UICC and moreso the global cancer movement. I also look very much forward to the coming two years of continued service and to working with Mary as she begins her terms as UICC President. I would also like to take this opportunity as a Board Member to thank you for your leadership and devotion to the organization and to the cause. It has been a pleasure to work with and for you and I do look forward to continuing this collaboration.
Dr. Prof. Ma is a well-known cancer researcher and expert in clinical radiation therapy. He has been active in UICC activities and a mentor or supervisor for many UICC scholars. He will make significant contributions to the future development and growth of UICC and to the fight against cancer. CV
Dr. Leslie Mancuso is the President and CEO of Jhpiego, an NGO affiliate of Johns Hopkins University that for nearly 40 years has worked with front-line health workers to design and implement low-cost, innovative solutions to strengthen the delivery of health care services to vulnerable women and their families. Innovations such as the Single Visit Approach (SVA), a unique, clinically safe, acceptable and effective approach to cervical cancer prevention for low-resource settings. In Thailand alone, over 600,000 women have been screened for the disease using this ground-breaking approach. Since Dr. Mancuso’s arrival at Jhpiego in 2002, the organization’s budget has grown from $5 to $140 million and the number of programs has expanded from 4 to 90. Jhpiego’s global staff now numbers over 1,200—of which 75 percent are in the field. Cervical cancer prevention efforts is an illustrative example where Jhpiego started with a SAFE demonstration project for SVA in 2 countries in 2002; and to date Jhpiego is supporting cervical cancer prevention activities in over 9 countries (Philippines, Thailand, Indonesia, Guyana, Peru, Mozambique, Cote D' Ivoire, Burkina Faso, Tanzania and Kenya. Dr. Mancuso’s vision is rooted in her belief that Jhpiego must develop sustainability-- the capacity of countries to create a well-prepared network of health care professionals that they can build upon to care for themselves. CV
Dr Merajver has the leadership skills to steer large scientific organ based cancer programs (over 8 years and 2 comprehensive core grant submissions as scientific director of the breast program), a clinical enterprise in risk communication and management (one of the oldest or the oldest risk evaluation clinic), and a University wide Center for Global Health, a unit with multiple startegic objective sinvolving students and faculty from all units of the UM. She has experienc eith national and internationl symposia and with memoranda of understanding with ministries, hospitals, clinics, non governmental organizations and Universities. CV
Dr. Nag is one of the world pioneers in brachytherapy and intraoperative radiation therapy for treatment of cancer patients He is a past-President of the American Brachytherapy Society and was awarded the Henschke Memorial Award for outstanding achievements in Brachytherapy. He has been named one of the Best Doctors in America for Brachytherapy for every from 1995 to present. He has served as an advisor or consultant to various agencies including the U.S. Nuclear Regulatory Commission, Union for International Cancer Control and the International Atomic Energy Agency. He has published over 200 scientific articles including textbooks in brachytherapy, book chapters, and the American Brachytherapy Society guidelines in brachytherapy. He has presented more than 500 abstracts and lectures in brachytherapy and intraoperative radiation therapy worldwide. CV
CV
Dr. Shidham is passionate about global cancer containment with emphasis on early detection and new avenues to manage cancers at early stage with additional interest in tumor angiogenesis as broader therapeutic approach. His experience and understanding about the field of cervical cancer with emphasis on cost effective, time proven approaches to detect and manage early cancer can be extrapolated to other cancers globally with incorporation of newer molecular ancillary modalities in appropriately effective manner instead of falling prey to superfluous glamour and aura if any associated to that area. Based on the observations as a cytopathologist and surgical pathologist, he noted that the strength of simple and low cost alternatives based on morphologic approaches have been underutilized with tremendous potential of cytopathology as contributing science to control cancer globally including poor developing world. His contribution as founding editor (and current executive editor & coeditor-in-chief) of open access CytoJournal (www.cytopjournal.com) to disseminate cytopathology research globally in open platform to retain it in public domain is widely acclaimed. CV
notes CV
Dr. Stambrook has served the cancer community at local, national and international levels. He is particualrly motivated to expand his contributions in the international arena and build on his past experiences. His contributions to date have been mainly as a basic cancer scientist, with involvement of some clinical trials that attempt to translate basic research findings to clinical application. He has been passionate about his work and wants to expand his efforts globally. CV
Amanda would add tremendous value to the UICC Board. In addition to being a cancer survivor, her experience in the corporate sector as a business executive would add a new perspective and skillset to the group. CVI hereby confirm my intent to continue service on the UICC Board of Directors in 2012
As a highly experienced clinician, clinical investigator, and basic scientist, Dr. Yen’s research interests focus on therapeutic research and identification of cancer markers. He is the co-leader for the Drug Cancer Therapeutics Program and is a leader in cutting-edge nanotechnology research to identify and treat cancer. Through his research Dr. Yen plays a critical role in improving health outcomes and cancer control. Dr. Yen holds membership in numerous professional organizations, including the American Association for the Advancement of Science, American Society of Clinical Oncology, Sigma-Xi Scientific Association, and Academy of Science New York. He has published more than 250 abstracts and peer-reviewed journal articles, and he serves as an ad hoc reviewer/referee for several journals and on the editorial board of the Journal of Clinical Colorectal Cancer. He sits on the advisory boards of the Taiwan Health Ministry, the National Health Research Institute, the Hong Kong and Singapore grant review committee, the NCI grant review committee, ASCO cancer research committee, and the AACR leadership council. He has significant global network and influence in cancer awareness which may help the UICC development in United States and Asia.
Dr Zendhdel, MD, PhD, is a well-known cancer scientits and invloved in both academic and governmental activites towrd cancer control program in Iran. He is deputy of Research in the cancer research center, Cancer Institute of Iran. He is scientitfic seretary of the national research network in the country, actively involve in the cancer registration, guideline developement, and establsihement of the national plan for the palliative care. He has a good sens of international collaboration and coperation. CV
Dr. Khaled is perhaps the most renowned precursor and advocate of cancer awareness and prevention programs in the gulf and the Arab region. A human catalyst whose distinctive contributions to the cancer profession has benefitted countless arabs today and the coming generations. Dr. Khaled specializes in radiation oncology and has written more than 30 scientific papers documenting mostly the clinical studies he made during his 28-years of experience in the field of oncology. Most of these papers were published in medical journals and presented to international fora and conferences he has attended. Dr. Khaled is a cancer advocate since his early years as a doctor. Beginning 1993, he has organized or supervised the conduct of at least 15 regional and international cancer conferences in Kuwait and in other gulf countries. Dr. Khaled has clearly recognized the need for cooperation and to unite the different cancer associations in the gulf. In 2001, he successfully initiated the first meeting to discuss the possible union of cancer associations under one umbrella organization. It was a success that in March 29, 2002, delegates of the gulf’s Council of Health Ministers and representatives of Yemen have officially announced the formation of the Gulf Federation for Cancer Control. There are 12 member-associations of this federation (http://www.gffcc.org/ journal/members.html). Dr. Khaled is the General Secretary of the Federation since 2003. CV
Dr. Al-Amoudi is a renowned clinician, researcher and breast cancer advocate in the Middle East, as well as globally, with a long list of accomplishments in both innovating and advancing the cancer agenda. Her vast experience professionally and personally, as a survivor, and leadership in the Middle East would be of great value to UICC. CV
As a woman in leadership in today’s complex world of affairs, AmeeraAbdelrahimBinkarambelieves strongly in herself and is confident of accomplishing any task she sets her mind to.An ardent advocate of women’s participation in economic activities, Ameera is a philanthropist, a social worker, and is proactive in issues concerning the environment as well. She provides strategic and operational leadership to many organizations dedicated to social and women’s causes.
) >40 years of research and clinical practice at academic, tertiary care uro-oncology centers (Depts.Urology,University of Mainz,Dept.Urology, Rudolfstiftung,Vienna, Dept.Urology, Med.University of Vienna). 2) 32 years of experience as as chief of urological departments (Chief, Dept.Urology, Rudolfstiftung Vienna 1980-1990;Professor of Urology and Chairman, Department of Urology, Medical University of Vienna, 1990- 2011), in these functions extensive experience also with all administrative aspect of leading large medical institutions. 3) Participant (and in some also principal investigator) in ~ 20 international , multicenter clinical trials, among them key studies for chemoprevention of prostate cancer (REDUCE, VIOX). 4) Active or Associate Member of the most important urological societies and Honorary Member of urological societies of countries all over the world. 5) ~ 580 publications in peer-reviewed journals , mainly on uro-oncology topics 6) Long-term activity on the boards of large international, urological societies, such as The European Association of Urology (presently Director of Regional Office) Societe international d´Urologie (Adjunct Secretary General, Vice President, presently Co-chairman,Scientific Committee; President,SIU Foundation) and The International Endourology Society (Past President).
Our nominee as a member of UICC Board of Directors is Prof Jean Bourhis. Prof Bourhis has a significant personal experience of leading both European and National scientific oncology societies including ESTRO and SRFO. In addition, he has extensive experience in cancer research through his leadership of multi-national co-operative clinical groups including GORTEC and MACH-NC. Prof Bourhis has a very strong track record of supporting the need for improved treatment access, the development of patient-centred guidelines and he is committed to the future development of improved multidisciplinary cancer care. The Society believes that this background in clinical service development and translational research gives Prof Bourhis a comprehensive understanding of the many challenges in further developing and advocating oncology needs at a global level. CV
Président de la Ligue Nationale Contre le Cancer, la plus ancienne et la plus importante des associations de lutte contre le cancer en France et Vice-Président de l’ALIAM (Alliance des Ligues Francophones Africaines et Méditerranéennes contre le cancer), je souhaiterais participer activement à l’action de l’UICC. J’ai fait toute ma carrière dans la lutte contre le cancer, chercheur, directeur d’institution, président d’une association caritative. Mon association souhaite que les initiatives prises en France et dans les pays francophones alimentent la réflexion et les actions internationales (lutte contre le tabac, défense des droits des malades, participation à l’élaboration de politiques de santé (démocratie) et vice-versa. Au-delà de la Ligue Nationale contre le cancer, je suis le porte-parole des associations francophones de lutte contre le cancer notamment celles implantées en Afrique et dans le pourtour méditerranéen qui m’ont mandaté au cours de la réunion des ligues francophones de Monastir en septembre 2011. En retour, je souhaite aider au développement de l’UICC dans ces pays. Avec mon expérience d’expert de la recherche, de l’organisation territoriale des soins et de la prévention, et mon expérience internationale, j’espère pouvoir contribuer activement aux actions et initiatives de l’UICC. CV
CVNomination for a second term as board member with the aim to further improve collaboration of the German Cancer Society with the UICC and its programms. CV
UICC is dedicated to fight cancer by various strategies. Actually this is exactly what we are doing at the German Cancer Research Center. Specifically, my work is focused on both, basic research and translational approaches to transfer new methods into the clinical routine. For this purpose, e.g. in silico modeling methods are applied and receptor specific tracers are developed to perform diagnostic studies as well as therapeutic interventions. Furthermore, we perform studies with functional imaging procedures and correlate the results to molecular biological data, achieving detailed knowledge about the dependencies e.g. of tracers on gene expression Due to the close interaction at the center, I am able to provide information about both, more clinical based methods as well as basic science. Based on my work for nearly 28 years at the Cancer Center, multiple international cooperations and contacts were established. This is important to provide information and get support for concerted actions. Of course, these links will be provided for the work with UICC. Another important aspect of my work is focused on educational and general information programs. There is a dedicated unit at the Cancer Center, which provides this information on a routine base to the public and we are closely cooperating with them. These links to media, etc. are important to support the work of UICC. Summarizing I like to state, that the work especially with translational projects is an important base to evaluate and support applications worldwide with the experience which is demanded. The numerous international contacts are helpful to establish a network for support for certain actions. Finally, the contacts to the media are important to get public attention for certain programs. CV
Prof. Catane has been serving for over 21 years as Head of renowned oncological departments/institutes in Israel. Today Prof. Catane is considered to be the leading oncologist in the country, and is actively involved in national activities related to legislation, regulation, policymaking public campaigns, media advocacy, and public education as related to clinical oncology. Prof. Catane is eager to share his vast clinical, administrative and scholastic experiences with the global community of professionals, which he feels could be done effectively by joining the UICC Board of Directors. CV
CV
With reference to my nomination for the B Self-nomination
Prof. Janusz Nauman
Dr. Radu Lucian Buzulica
Mrs. Jasmina Rudic
Dr Priscila Torres Babié
Self-nomination
Willingness to continue
Dr. Kathryn Allen
Bangladesh Cancer Society
Prof. R.A. Badwe
Mrs Renuka Prasad
Self-nomination
Prof. Nila Moeloek
Self-nomination
Activities done by UICC are uniqe and co Self-nomination
Dr Manjari Peiris
Self-nomination
Willingness to continue
Dr. Maggie Watson
Self-nomination
Prof. Guozheng Guo
Willingness to continue
Willingness to continue
Self-nomination
Motivation notes CV NominatorDr Ana Garces
American Cancer Society, Fellicia Hannibal
Dr E. Cazap & Dr M. Gospodarowicz
Self-nomination
Prof. Michael Silbermann
Bangladesh Cancer Society
CV
Anne Lise Ryel is an experienced lawyer, a seasoned politician, and since 2002, the Secretary General of the Norwegian Cancer Society (NCS). She has expressed her willingness to serve as member of UICC’s Board of Directors for one or two terms. To the UICC Board of Directors, she will bring a wealth of experience and access to a broader and resourceful network of able individuals within politics, academia, civil society and the legal profession. Anne Lise worked as State Secretary in the Norwegian Ministry of Justice in Prime Minister Stoltenberg´s first Government. The State Secretary ranks second after the Minister in seniority, and acts in effect as vice-minister in the daily work in the treatment of political issues. In addition, she served as Deputy Director General at the Norwegian Directorate of Health. In these qualities as political and government representative, she has developed knowledge and skills, and a web of useful contacts with political and policy makers in the Norwegian political landscape across ideological lines. She also has very good knowledge and contacts with civil society actors. Anne Lise served as the Norwegian Gender Equality Ombudsman for six years. The Ombudsman has a position similar to a judge. As an ombudsman, she was responsible for overseeing and implementing Norway’s Gender Equality Act. She is a person with moral integrity, honesty and adherence to high ethical standards. She is an excellent negotiator and communicator. She is also known for her skills at building bridges. She is a team organizer and has excellent ability to act within a team setting. For the last 25 years she has been appointed to serve on boards in all areas of society. Anne Lise was head-hunted to lead the Norwegian Cancer Society (NCS), one of the most significant NGOs in Norway. NCS is very popular and has a very good reputation. With Anne Lise, the Norwegian Cancer Society has broadened and intensified its activities in the domains of health promotion, cancer research and prevention, and patient support, and advocacy has become an important area. Anne Lise is often used as a speaker at conferences and meetings and appears often in media (TV, radio, newspapers), being “the voice” and “the face” of the cancer cause. In addition Anne Lise has written many articles the last twenty years. A cancer survivor herself, she was nominated Global Cancer Ambassador by the American Cancer Society in 2011. The Norwegian Cancer Society included “International Cooperation” as its fifth priority area under her leadership. In the area of International Cooperation, the Norwegian Cancer Society is a pioneer in Scandinavia. The organization has tobacco control and cancer screening projects in Africa, Russia and Peru. It also supports tobacco control civil society capacity building in these geographic areas. The collaboration has achieved very good results. Anne Lise has participated to many national and international meetings. Her recent international meetings include the following: the Moscow Ministerial Conference on Healthy Life-styles and non-communicable diseases (NCDs), the Civil Society Informal Meeting in New York and the High Level Meeting on the prevention and control of NCDs at the United Nations. She was a member of the Norwegian official delegation representing the Norwegian NCD-network both in Moscow and at the United Nations. She has also taken part to meetings on behalf of the UICC. She is a member of the partnership group of the International NCD Alliance. Anne Lise has also been a member of boards at the United Nations, WHO and the European Union, as well as to several ministerial delegations to global conferences. Anne Lise has established important contacts with key players on the world health and development scene. UICC is playing a significant role within the international NCD Alliance. As a member of the Board of Directors, Anne Lise’s experience with participation to all the processes in connection with UN High Level Meeting can be put to good use. The Board of the Norwegian Cancer Society and all the employees of the organization fully support Anne Lise’s candidacy to become a member of UICC’s Board of Directors. She will contribute to UICC’s work and development to her best expertise. She is available to attend the meetings and other communications of the Board and any other committees that she would be appointed to. CV
Mr Maxime Compaore (NCS)Ms Elizabeth Hjorth, Danish Cancer Society
Barbara Jarząb seems to be appropriate candidate for following reasons: 1. During more than 30 years when I follow her carrier she proven to be exceptionally gifted, intelligent, very responsible and hard working person able to work alone in the team. In addition Prof Jarząb has shown to be very good teacher, perfect organizer and leader of her group. 2. Barbara Jarząb completed her medical study with honors and received her MD in 1975 at the Silesian University Medical School, Katowice, Poland. During the period of 1975 - 1992 she has been employed as a academic teacher and research associate in the Silesian University School of Medicine first with the position of associate at Department of Biology, Laboratory for Experimental Endocrinology and then with the position of assistant-professor at Department of General Surgery and Nuclear Medicine Unit. During these years the Candidate improved her knowledge and skills both in basic science and clinical medicine. She became Board approved specialist in pediatrics (1986), and then endocrinology (1991). In 1980 she defended her PhD thesis and received the degree of PhD. Between 1982 and 1984 dr Jarząb has been working in the Department of Clinical Endocrinology, Hannover University Medical School (German Academy Exchange post-doctoral fellowship} In the Second part of 1984 dr Jarząb attended Summer School of Brain Research at the Netherlands Institute of Brain Research in Amsterdam and in 1987 she has spent few months at the University of Helsinki to learn techniques of molecular genetics. In 1990 dr Jarząb presented her habilitation thesis and the Scientific Board of Faculty of Medicine, Silesian University Medical School decided to give her the scientific degree of docent. (equivalent to DSc.). 3 In autumn of 1992 docent Barbara Jarząb left Silesian University Medical School and move to the Maria Skłodowska-Curie Memorial Cancer Institute, Gliwice Branch to take the position of Head of Department of Nuclear Medicine and Endocrine Oncology. During next 12 years she became Board approved specialist in nuclear medicine and received the scientific tittle of professor of medicine. In this period she modernized the Department of Nuclear Medicine, organized the Laboratory of Molecular Biology sufficiently to start whole genome study in the patients, organized Informatics Unit and Out-patient Clinic to follow up the effects of treatment in patients with thyroid cancer and cancers of endocrine system. All these proven that dr Jarząb has ability to collect resources and positively cooperate with her supervisors and colleges from other Departments of Gliwice Branch of MSC Memorial Cancer Institute. Her obvious, probably most important success was to build the inter-disciplinary team of epidemiologists, pathologists, biochemists, molecular biologists, informatics, oncologists and specialists in nuclear medicine. She proven she has ability to organize and lead team work within the Department as well as tightly cooperate with surgeons or clinical pharmacologists. Quality of medical service given to the patients in the Department of Nuclear Medicine and Endocrine Oncology resulted in international recognition of the Unit and Prof. Barbara Jarząb .It soon was followed by including both Prof Jarząb and the Department in international multi-center research studies in oncology. 4. Prof Barbara Jarząb activities extend very much her work within the Maria Skłodowska-Curie Institute of Oncology. In 2000 she started to organize the Polish Thyroid Cancer Research Network which at present is an working “arm” of Polish Society of Endocrinology, Polish Thyroid Associetion, Polish Society of Oncology, Polish Society of Surgeons, Polish Society of Oncological Surgery, Polish Society of Pathology, Polish Society of Nuclear Medicine and Polish Society of Ultrasonography. The Network in 2006 presented first Polish guidelines for diagnosis and treatment of thyroid cancers and this important document was updated and extended in 2010. In addition the Network organize yearly conferences to update and optimize pathological diagnosis of cancer, extend of surgical treatment, role of 131I therapy and prevention and the comprehensive therapy of medullary thyroid cancer. In addition the Network is also active in the public education in different aspects of prevention and treatment of Cancers of endocrine system. 5. Prof Jarząb is also active in the European Thyroid Association Cancer Research Network where she has been voted to be Secretary. 6. In the past Prof Jarząb was voted to be a Member of Executive Committee of European Thyroid Association and since 2011 she was chosen to be Secretary of Executive Committee of European Society of Endocrinology. 7. Since 2011 Prof Barbara Jarząb held the position of V-Chairman of Scientific Board at the Maria Skłodowska-Curie National Cancer Institute in Warsaw CV
CV
To be in a responsible and challenging position, where I can contribute quality and safety improvement of care to patients, implementation of medical waste disposal plans in countries in transition CV
Some friends and colleagues have proposed my candidature to the UICC Board of Directors. After some consideration of the responsibility that implies in case I were elected I feel that after so many years working in the field of cancer in different positions, this is an opportunity and to offer the experience and knowledge I have to help to accomplish the aims of a global organization dedicated to the cancer such as the UICC. As it can be seen from my CV I was first working in the clinical field as an oncologist and afterwards within the Basque Country (Spain) administration where I have had the opportunity to get experience in fields such as: cancer registration, cancer epidemiology & research, collaborating in population based screening programs and in the planning of services and resources for cancer patients among other tasks. On the other hand, I have been involved in Spanish professional associations and also international ones such as European Network of Cancer Registries (ENCR) and International Association of Cancer Registries (IACR), in some of them in the executive committees, which have given to me the opportunity to collaborate from a different position in formulating new policies for the group and to be in touch with other populations to evaluate the meaning of cancer situation for them. Of great interest were the meetings promoted in Africa. A particular interest during these years has been dedicated to Central& South America and Caribean countries. Having the same language was a very important tool. A network, Redepican, financed by CYTED was established with several groups from these countries. In relation to cancer epidemiology and registries various activities were developed: training, research projects and two guides to standardized criteria in the registries were written. Some exchanges were possible through the ICRETT fellowships. I understand that nowadays, cancer is affecting any population in the world. It is a global disease. And the solutions must be global as well. However activities must be very well defined to obtain good outcomes because the problem is heterogeneous and complex. There is a rapid pace of development of new drugs and techniques for cancer patients but to defeat cancer I think that is necessary the role of everyone. If I can be there with my voice and ideas within a global organization such as UICC I will consider it an honor. CV
CV
CV
Marilyn is a tireless and visionary international campaigner who has dedicated more than 30 years to cancer prevention research and health information. With her extensive knowledge and experience of working at an international level, together with her sheer determination to make a positive difference to cancer prevention and control, Marilyn is perfectly placed to further the goals of the UICC as a Board member. CV
I am involved in oncology field since 1990. In addition to my clinical works, I am involved in many social organizations. I am the elected President of Bangladesh Cancer Society (BCS) from 2009 till date. It may be noted that being the valued member of UICC from 1995, Bangladesh Cancer Society is relentlessly working on cancer detection, prevention, treatment and research. BCS observe all the cancer related international Days and Months in befitting manner every year and organizing national and international oncology related seminar, symposium, workshop and conferences. As the Treasurer of United Forum Against Tobacco (UFAT), I am involved vigorously in anti-tobacco campaign. I have been working with the government as the Director and Professor of Radiotherapy of National Institute of Cancer Research and Hospital, country’s only tertiary level specialized cancer centre. At present, I am also the National Project Coordinator of IAEA, and member of American Society of Clinical Oncology (ASCO). I finished my Doctor of Medicine (M.D) from Donetsk State Medical Institute, Ukraine (The Then USSR) in 1982 and then got Post graduation Training on Gastroenterology up to 1983. I completed my Post Graduation in Oncology, Diploma in Medical Radiotherapy (DMRT) in 1992 from Dhaka University. I got higher training in Oncology from France, China, India, Sweden, Netherlands, Germany, USA, Italy and Malaysia. We have cooperation and collaboration pact for mutual exchanging and sharing our knowledge with University of Sydney, Australia and Darmstadt Academic Medical Institute, Germany. It can also be stated that more than fifty thousand cancer patients are treated under the auspices of Bangladesh Cancer Society Hospital & Welfare Home, Fatema Rahman Cancer Hospital & Research Institute and National Institute of Cancer Research Hospital. I am a Executive Member of Bangladesh Medical and Dental Council, the national regulatory body in medical field. I am a life member of Bangladesh Cancer Society, Bangladesh Medical Association, Bangladesh Society of Radiation Oncologists and Dhaka University Registered Graduate Forum. I am the Executive editor of Bangladesh Cancer Reports Journal and Chairman of Editorial Board of Journal of National Institute of Cancer Research & Hospital. I have more than 110 scientific publications in national and international reputed journals. I am the founder of Fatema Rahman Cancer Hospital & Research Institute, Professor Dr. Obayedullah-Ferdousi Foundation and Professor Dr. Obayedullah-Ferdousi Medical Institute serving as a pioneer cancer care organization in all over the Bangladesh through cancer control, detection, treatment and research. I got many national awards for the recognition of my service, including DR. Md. Shahidullah Gold Medal Award, Award for Mother Tongue & Mother Land Gold Medal, Mother Teresa Shining Personality Award etc. CV
The Tata Memorial Hospital plays a lead role for Service, Education and Research not only in India, the South East Asia region but globally as well. The hospital caters to the training of about 70% of the manpower required nationally in the field of Oncology. It is on the forefront of propagating evidence based guidelines relevant to the region and run programmes for the prevention and early detection of cancer. The Hospital also serves as adviser to the Department of Health, Government of India for planning Oncology care delivery for India. Dr. D’Cruz being the Director of the Hospital in addition to being a Head & Neck Surgeon plays a pivotal role in the coordination of these activities of the hospital. Dr.D’cruz looks after the international collaboration between TMH and other national and international institutions and agencies and has been an excellent conduit for sharing ideas and data. His presence therefore on the Board of Directors of the UICC will be of immense benefit in furthering the mandate of the UICC. CV
Indian Cancer Society (ICS) is the oldest Cancer NGO in India founded in 1951. It is a national organization headquartered in Mumbai, India. Jyotsna has been at the helm of the organisation ever since I joined it in 1998. She has been a motivational force in the community projects where regular awareness talks are conducted and detection work is carried out. She has worked for the survivor ship issues where the tag of having had cancer is not a taboo but one to be lauded for having overcome and fought the cancer against all odds. She inspires the volunteers immensely with her own example of selfless dedication to the cause of cancer. She is working relentlessly in the various fund raising projects for the organisation and motivates all the volunteers in such related activities. She would be an asset in working with the UICC as its director CV
To work at grassroot level to prevent cancer and detect cancer at early stage amongst the poorer section of the society which forms the majority of the national populaiton in a developing country like Inida CV
Assisting the Government through the Ministry of Health in cancer control programmes. To increase services for cancer patients in Indonesia through international networking. CV
When one of my relative has suferred from breast cancer in 1990, when I was resident doctor in Nepal, after having Mastectomy here, I took to her to India for Chemotherapy and Radiotherapy, and I came to know the problem faced by cancer patients in Nepal. Very soon, our prime minister was scheduled to visit china, i convinced him about the need and importance of cancer hospital in Nepal. Interestingly, his brother, B P Koirala, the first elected priminiter of Nepal died of cancer, so he requested to chinese government for grant to build B P Koirala Memorial Cancer Hospital (BPKMCH), where i worked from established as Chair of Surgical Oncology Department and deputy executive director.Sametime, i joined Nepal Cancer Relief Society and contributed actively to sign and ratify FCTC in Nepal.I have leading the oncological healthcare professional for cancer awarness, anti-tobacco campaign and participating world cancer day and no tobacco day every year. I had training at world renowned institute in the world, and have presenting papers in national, regional and international conferences. So, if given the chance to me, i willl do my best to gain the noble goal of UICC. CV
CV
The nominee, Dr. Samadhi Rajapaksa is fully devoted and committed to charity work and spending most of his time in counseling or sitting down with cancer patients. Upon his return from the University of Vitebsk on completion of his study in medicine with Honours, Dr. Samadhi Rajapaksa commenced working at Anuradhapura (in the Central Province of SL) as an intern doctor. During this period he could realize how much it would help a patient when a doctor whispers a kind world, is much concerned about patients inquiring into them drawing his personal attention and being a kind doctor willingly listening to them. His quality of paying attention to patients was further extended by helping the cancer patients and monks who visited the hospital by providing them with refreshments before attending to their complaints or grievances since most of these people were traveling from far off villages. Dr. Samadhi has a healing and caring touch with a compassionate heart for the sick and the poor. His vision and mission is not an easy one, though he continues his work with utmost devotion and untiring commitment. He established a charity organization in 2003 (Cancer Care Association) to extend his services towards cancer patients in many forms, not only to support them with everyday financial and medical needs to cope with painful situations, but also to help them by providing spiritual support to mentally overcome various problems on becoming cancer patients. Dr. Samadhi is constantly helping the National Cancer Institute too in providing expensive drugs and equipments needed for cancer patients and supporting research/investigations by using his good rapport with many philanthropist individuals and institutions. Returning to normal life is a challenge indeed to an oncology patient as well as their families in many forms. Dr. Samadhi provides ongoing support to cancer patients through counseling and enables them to dispel their fears and anxieties. He pioneered to establish a hospice with a capacity of accommodating 45 cancer patients (in outstation) last year to help “terminally ill cancer patients”. This is the first occasion in the history of Sri Lanka that an individual has pioneered to establish a hospice and it is the only one available in outstation. This activity of Dr. Samadhi alone is the best example to witness his suitability to be a leader in the field of palliative care. Dr. Samadhi who is an expert in providing palliative care to cancer patients has now begun to providing home-based palliative care too. Dr. Samadhi is not merely a medical professional, but a human being with a feeling, a heart and thirst for helping the sick, especially cancer patients! The contribution extended by Dr. Samadhi for the activities being launched by Jeewaka Foundation towards achieving its vision to prevent people from smoking and to minimize the spread of cancer by raising community awareness with the involvement of media and medical professionals as well as drawing the attention of policy makers is commendable. In Sri Lanka smoking is responsible for 40% of cancers and one third of the population is smoking. At present he is campaigning to pressurize Sri Lanka government to implement the regulation on Pictorial Health Warnings on tobacco products and enlightening the media, medical professionals and policy makers on the provisions of the Framework Convention on Tobacco Control (FCTC) of the World Health Organization. Taking into consideration the above information Jeewaka Foundation is confident that Dr. Samadhi Wishvanath Rajapaksa would be a good fit for the position of UICC member of the Board. CV
Professor Emeritus Kobchitt Limpaphayom was recognized by the the King of Thailand and awarded the title of Khunying (Lady) for her dedication and contribution to improving the health and well-being of Thai women in particular and for her work in the region and globally. She was also recently awarded the honorary degree of Doctor of Medicine from Chulalongkorn for her achievements in medicine, public health and education. As the Chairperson of the Royal Thai College of of OB-GYN in late 1990s, she undertook a partnership with Jhpiego and Chulalongkorn to conduct a safety, acceptability, feasibility and effectiveness (SAFE) study on VIA and Cryotherapy in a single visit approach utilizing mid-level providers as care givers. Ten or so years after the study, Prof Limpaphayom has been instrumental in ensuring that the cost-effective approach to cervical cancer prevention is accessible. To date, over 22 provinces have the service in place. In the effort to protect the next generation of women, she also is participating in a mother-daugther initiative to integrate both screening and vaccination. Prof Limpaphayom continues to be actively engage nationally, regionally and globally in pushing the envelop for practical and effective means to cervical cancer control. CV
Statement from the Candidate. Cancer is a global problem. The UICC is uniquely placed to mobilise and then bring to bear the considerable resources of its worldwide membership to deliver on the promise of cancer control, that is, our shared vision for a cancer free future. For nineteen years I have worked with the UICC and its member organisations, in various capacities, and remain a proud servant in the pursuit of its mission. If elected to the Board of the UICC, I would commit wholeheartedly to the work of the organisation and willingly share my skill and experience to further its objectives. I would welcome the opportunity to serve. Statement from the President of IPOS. Prof. Dunn joined the IPOS Board in May 2010 and has been an extremely engaged and active participant on the Board since that time. He has made significant contributions by developing innovative programs in support of our strategic plan, and then in leading implementation as agreed by the Board. It is with utmost respect and pleasure that I highly commend Prof. Dunn for election to the UICC Board of Directors. Professor Dunn was invited by me to join the editorial board of the Psycho-Oncology journal, the leading journal in our field. His contributions to the journal have been of the highest standard. I commend his as someone with a strong international reputation who has made a clear and beneficial impact on patient care. Respectfully submitted, Prof. Maggie Watson, President of IPOS. Statement from the Executive Director of IPOS. I have known and worked with Prof Dunn for the two years since he has joined the IPOS Board. In this time he has proven to be a diligent advocate for the mission and vision of IPOS, bringing forward creative and effective plans and programs. He is effective in following through with implementation of his commitments. He is a collaborative and highly esteemed leader and has earned the respect and appreciation of his colleagues on the Board and the IPOS staff that have the pleasure to work with him. Respectfully submitted, Elliott Graham, Executive Director of IPOS. CV
I accepted the request from the New Zealand Cancer Society that they nominate me for a position on the UICC Board. I want to outline my vision for this role and UICC. I have been a member of UICC for many years and attended my first UICC Congress in Hamburg in 1990 when I was practicing as a medical oncologist. As CEO of Cancer Council Australia I led the successful bid on behalf of the other Cancer Council members for the UICC 2014 Congress in Melbourne. It would be helpful to serve on the Board over the lead up to that meeting. In my role at Cancer Council Australia we have an ongoing relationship with UICC supporting the APCASOT and ICRETT Fellowships, as well as funding the membership fees for developing countries in our region. We also joint funded a position with UICC to help co-ordinate the Australian response to the UN high level meeting on NCD’s. In terms of my vision for UICC I would like to see a greater focus on addressing the disparities in cancer control between the developing and developed world1. I certainly have proposed including the issues of the SE Asian and Western Pacific region in the 2014 meeting, but opportunities need to be ongoing. I have personal experience in a longstanding commitment to mentoring medical oncologists in hospitals in India but recognise that there are many such initiatives which remain unco-ordinated. I would support the concept that all of the educational materials generated by the congresses become a digital repository of information which is then freely available to programs in developing nations. I strongly support the role of UICC in international advocacy. As part of an organisation charged with the responsibility for national advocacy in cancer control it is helpful to have an international organisation to link with who can translate that internationally and useful for international success to be a source of data to support lobbying locally. I want to explore synergies between UICC and other national and international organisations. I am a longstanding member of ASCO (American Society of Clinical Oncology), most recently having served on their Ethics committee. I serve on the Palliative Care working group of ESMO (European Society of Medical Oncology) and am on the Board of MASCC (Multinational Association for Symptom Control in Cancer) and edited their textbook on Cancer Supportive Care and Survivorship with authors from 17 countries. I am on the Council of the Clinical Oncological Society of Australian and their International Affairs Working Group. All of these organisations have some overlapping goals and there may be synergies to be explored. CV
Samoa Cancer SocietySociety of New Zealand
1.Experience on clinical pathological diagnosis on head neck cancers & odontogenic tumours & salivary gland tumours. 2. Experience on molecular pathology on head neck cancers & odontogenic tumours & salivary gland tumours 3. Research experiences 4. International collaboration experience 5. Leadership and organization on clinical and research works 6. Good communication 7. Honest and can be trusted CV
CV Dr Yanfei LiuDr Lijun Zhang
I am happy to volunteer myself to be in the Board of Director for UICC. I’m currently the President of Malaysian Oncological Society, Past President for The Asian and Pacific Federation of Organization for Cancer Research and Control (APFOCC) and Vice President of South East Asia Radiology Oncology Group (SEAROG) from 2011 to 2013. My involvement is not only locally in Malaysia but also in Asian Region. If the committee agreed, I would happy to serve in the Board of Director. I enclosed my CV for your perusal. CV
Professor Cecilia Llave has over 30 years of increasingly responsible positions within the Philippjne General Hospital's Gyneoncologic Services as well as in the professional community of practitioners. From January 2001 to March 2010, she was the Chair of the UP-PGH Cancer Institute and concurrent Chair of the PGH Tumor Board. With regards leadership roles in major professional societies, she is presently a Board Examiner, was a Board Member (2005 – 2009) and Past President (2003-2004) of the Philippine Society of Cervical Pathologists and Colposcopists (PSCPC); Vice President (2011 -2013), Society of Gynecologic Oncologists of the Philippines (SGOP); Fellow, Philippine Obstetrical and Gynecologic Society (POGS); former Board Member, Philippine Society of Oncologists (PSO); Lifetime Member, Lecturer Board Member (2011), Philippine Cancer Society (PCS); President elect of AOGIN, Philippines. Since April 2010.she is the Program Director for the Cancer Institute Foundation. She also recently accepted a visiting professorial grant at the Kobe University Graduate School of Medicine for the International Activity for Health Programs. Professor Ladines-llave has educated a generation of healthcare providers as well as published her work lin local and international publications. As detailed in this succinct overview of Professor Ladines-llave's achievements, her singular effort is to bring excellence to women's cancer prevention and care to the Philippiines. Professionally she has expanded her horizons from individual clinical care to population based effort to address both pre-cancer and cancer-catching them early for simple but effective treatment can be afforded. Her goal has always been bringing down the number of people who get cancer and die of it. CV The Cancer Institute Foundation, Inc.
I am deeply motivated to serve UICC as a person from a developing country who knows the needs of developing countries, and am looking forward to working together with other organizations from multiple countries to control cancer. I am a deep believer of cancer prevention and early detection and hope to be able to bring this message to a very wide population.
On behalf of the American Cancer Society, I would like to recommend that Dileep G. Bal, MD, be considered as President-Elect of the UICC National Board. Dr. Bal is a globally recognized leader in Cancer Prevention, Cancer Control, and Cancer Research. Dr. Bal is well prepared for and ready to make substantial contributions to advancing the mission of UICC as an active member of the UICC Board of Directors given his outstanding life achievements and leadership positions in advancing the global fight against cancer. As a result of his numerous accomplishments and achievements as a dedicated public servant, Dr. Bal has earned a reputation for making courageous decisions and taking the risks necessary to advance the cause of public health in general and tobacco control in particular to unprecedented levels of effectiveness and would be a dynamic asset to the UICC Board.CV
Dr Cavalli is a global cancer leader , internationally recognized as a prestigious scientist , politician and strategical thinker. Former President of UICC. CV
As a practising academic pediatric oncologist, scientist and professional health care executive in Turkey, I have observed very closely the difficulties and challenges in improving the healthcare. Then I decided to involve in health care management at professional level and NGO management. I am involved in the quality improvement project of Turkey’s leading Hospital, Hacettepe University Hospitals, and be able to accredited the whole hospital complex by US Joint Commission International. I have involved many national and international project on cancer control. My society is a member of UICC since 1969 and I personally have been working with UICC very closely more than 10 years. During those years, I was able to contribute to cancer control activities in my country and learnt a lot from UICC experience and I also had opportunity to share my knowledge and experience with UICC community. I personally feel myself belonging to UICC community. During the last two years, cancer has been on global agenda more than previously it had. With my management and NGO background together with my international experience, I think I could be helpful for UICC and ready to serve for UICC as president. CV
Prof. Murat Tuncer has been intimately involved in promoting cancer control programs while serving as the Head of the Cancer Control Department in the Turkish Ministry of Health during the periof of 1992-2011. His initiatives yielded dramatic changes in the entire outlook of Turkish government on issues related to cancer control and management nationally. CV
Dr. Chen Zhu is an outstanding scientist with top-notch expertise in molecular oncological studies and treatment against acute promyelocytic leukemia. Dr. Chen has, together with his colleagues at Shanghai Jiaotong University Medical School, pioneered the highly effective and well-acclaimed all-trans retinoic acid (ATRA) and arsenic oxide cocktail therapy against acute promyelocytic leukemia (APL), based on induced differentiation and apoptosis, with surprisingly high 5 years survival rate (from 25% to 95%) for this notoriously malignant cancer afflicting numerous patients worldwide. His remarkable accomplishments have been recognized internationally as evidenced by his most recent official nomination as one of the two 2011 recipients of the 7th Annual Szent-Györgyi Prize for Progress in Cancer Research, sharing with Dr. Zhen-Yi Wang, his former mentor and colleague, an honor established by "the National Foundation for Cancer Research to recognize outstanding scientific achievements in the war against cancer and to honor pioneering scientists who have made extraordinary contributions in cancer research." Dr. Chen has published over 300 original research paper in peer-reviewed international journals like Science, Nature Genetics, PNAS, EMBO J, J Exp Med, JCI, Blood, Am J Hum Genet, Oncogene, Leukemia and domestic journals, with citations over 9400 times. Dr. Chen is not only an academic leader, but also an eminent politic figure with global vision and international presence. Over the years, Dr. Chen has diverse and very competent administrative experiences in steering a plethora of organizations including academic research centers, The Chinese Academy of Sciences (as Vice-President during 2000-2007), The Ministry of Health of P.R. China (2007-present), China Medical Association (as president from 2010 onward), international organizations like IAP, the global networks of academies (two terms from 2004-2006 and 2007-2009) etc. His functions at these positions are mostly relevant to academic research and prevention of, diagnosis and treatment to cancer. Dr. Chen's connection with UICC is evidenced by his attendance at the launching of UICC CHINA SPOKE in 2009, his interview in 2009 with Dr. David Hill, UICC former president, his attendance to the UICC World Cancer Congress of 2010 Shenzhen, China and delivery of plenary speech during the opening ceremony on August 18, 2010. His international exposure thus far foretells his big potential as a world-class organizer in human battle against cancer. Dr. Chen has excellent personalities in dealing with people, showing great concern for the rural population in China and having adopted a series of measures to better medical service to citizens of China through prevention, early diagnosis and treatment. A very talented bright scholar, educator and public leader, Dr. Chen enjoys welcome and respect from the majority of those dealing with him. Thus I have full reason to believe that Dr. Chen Zhu is highly qualified to be considered for the prestigious position of UICC President-Elect 2012. I trust that Dr. Chen, upon official appointment by UICC Nominating Committee, will perfectly function to meet all expectations carried by the position of President-Elect for furthering the global impact and image of UICC
Dr Wan-Hui Zhang, Dongguan University of Technology
Dr. Nina Hurwitz
Prof. Julio LicinioCV
Email Address Support received from
[email protected] Said Mchangama, Président de l'Union Comorienn
Elizabeth Hjorth, Legal Advisor, Danish Cance
Ms.ZHAO Weili, Project Manager, Dept. of International Relations, Chinese Medical Association
Email Address
[email protected] [email protected]
[email protected]@cma.org.cn [email protected]
[email protected]@slacom.org
Support received from
Professor Farhat Ben Ayed, President Committee ATCC
Cora Honing MA, International Affairs Officer, Dutch Cancer Society
Ms.ZHAO Weili, Project Manager, Dept. of International Relations, Chinese Medical Association
